We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 204.05
Bid: 204.00
Ask: 204.10
Change: 1.35 (0.67%)
Spread: 0.10 (0.049%)
Open: 200.75
High: 205.25
Low: 198.84
Prev. Close: 202.70
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Final Results

15 Feb 2023 07:00

RNS Number : 9336P
Barclays PLC
15 February 2023
 

Barclays PLC

 

2022 Results Announcement

 

31 December 2022

 

Results Announcement

Page

Notes

1

Performance Highlights

2

Group Finance Director's Review

6

Results by Business

Barclays UK

8

Barclays International

11

Head Office

16

Quarterly Results Summary

17

Quarterly Results by Business

18

Performance Management

Margins and Balances

24

Remuneration

26

Risk Management

Risk Management and Principal Risks

28

Credit Risk

29

Market Risk

49

Treasury and Capital Risk

50

Statement of Directors' Responsibilities

63

Condensed Consolidated Financial Statements

64

Financial Statement Notes

69

Appendix: Non-IFRS Performance Measures

77

Shareholder Information

84

 

BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.

 

Notes

 

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the year ended 31 December 2022 to the corresponding 12 months of 2021 and the three months ended 31 December 2022 to the corresponding three months in 2021 and balance sheet analysis as at 31 December 2022 with comparatives relating to 31 December 2021. The historical financial information used for the purposes of such analysis has been restated. Please refer to Supplementary Information contained herein for further information. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.

 

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

 

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.

 

The information in this announcement, which was approved by the Board of Directors on 14 February 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

 

These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.

 

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

 

Non-IFRS performance measures

 

Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 77 to 83 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

 

Forward-looking statements

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's reputation, business or operations; the Group's ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the SEC (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2022), which are available on the SEC's website at www.sec.gov.

 

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Performance Highlights

 

In 2022 Barclays delivered a profit before tax of £7.0bn and return on tangible equity (RoTE) of 10.4%, with total capital distributions equivalent to c.13.4p per share

 

C. S. Venkatakrishnan, Group Chief Executive, commented

"Barclays performed strongly in 2022. Each business delivered income growth, with Group income up 14%. We achieved our RoTE target of over 10%, maintained a strong Common Equity Tier 1 (CET1) capital ratio of 13.9%, and returned capital to shareholders. We are cautious about global economic conditions, but continue to see growth opportunities across our businesses through 2023."

 

 

Key financial metrics:

 

Income

Cost: income ratio

Profit before tax

Attributable profit

RoTE

EPS

TNAV per share

CET1 ratio

Total capital return1

FY22

£25.0bn

67%

£7.0bn

£5.0bn

10.4%

30.8p

295p

13.9%

c.13.4p equivalent

Q422

£5.8bn

69%

£1.3bn

£1.0bn

8.9%

6.5p

 

Demonstrating execution against our three strategic priorities:

 

·

Deliver next generation digitised consumer financial services: simplifying and upgrading online banking services - with over 10.5 million Barclays UK mobile banking app users, and log-ins up 8% year-on-year. c.220k 'Rainy Day Saver' accounts opened online since launch on 29 September 2022, 41% are new or re-joining Blue Rewards customers. In the US Consumer Bank, the Gap portfolio2 integration onto our platform doubled our US customer base to over 20 million

·

Deliver sustainable growth in the Corporate and Investment Bank (CIB): 114bps of revenue share gain in Global Markets from 2019-20223; second fastest growth rate across the top 10 global peers. Investment in Financing businesses delivered more stable, high returning income of £2.9bn in 2022 reflecting a compound annual growth rate (CAGR) of 16% since 2019

·

Capture opportunities as we transition to a low-carbon economy: new expanded target to facilitate $1 trillion of Sustainable and Transition Financing by the end of 2030. The Group's Sustainable Impact Capital investment mandate is now £500m by the end of 2027

 

2022 Performance highlights4:

 

·

Group attributable profit of £5.0bn and RoTE of 10.4%, with all operating divisions delivering double-digit returns

-

Excluding the impact of Over-issuance of Securities in the US (Over-issuance of Securities)5, RoTE was 11.6%

·

Group profit before impairment of £8.2bn, up 9% year-on-year

·

Group income of £25.0bn, up 14% year-on-year with broad-based momentum across our operating divisions and the benefit from FX:

-

CIB income increased by 8%; the best full year for both Global Markets and FICC6, and strong performance in Transaction banking, more than offsetting the impact of a reduced fee pool in Investment Banking7

-

Consumer, Cards and Payments (CC&P) income increased by 35% supported by higher balances in US cards and Private Bank with turnover growth in Payments

-

Barclays UK income increased by 11% primarily driven by the rising rate environment

·

Group operating expenses were £16.7bn, reflecting £1.6bn of litigation and conduct charges, primarily driven by the Over-issuance of Securities

-

Group operating expenses excluding litigation and conduct were £15.1bn, up 6% year-on-year, reflecting the impact of FX and inflation

·

Credit impairment charges were £1.2bn, with a loan loss rate (LLR) of 30bps, reflecting macroeconomic deterioration, partially offset by the utilisation of post-model adjustments (PMAs) for macroeconomic uncertainty and the release of COVID-19 related adjustments informed by refreshed scenarios. Coverage ratios at the portfolio level remain strong

·

CET1 ratio of 13.9% and tangible net asset value (TNAV) per share of 295p

·

Capital distributions: total dividend for 2022 of 7.25p per share (2021: 6.0p), including a 5.0p per share 2022 full year dividend. Intend to initiate a share buyback of up to £0.5bn, bringing the total share buybacks announced in relation to 2022 to £1.0bn and total capital return equivalent to c.13.4p per share

 

1

Includes total dividend for 2022 of 7.25p per share and total share buybacks announced in relation to 2022 of £1.0bn.

2

The Gap portfolio refers to the Gap Inc. US credit card portfolio.

3

Barclays' calculations using Peer reported financials.

4

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

5

Denotes the Over-issuance of Securities under Barclays Bank PLC's (BBPLC) US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See page 5 for reconciliation of Barclays' performance excluding the impact of the Over-issuance of Securities.

6

Period covering 2014-2022. Pre 2014 data was not restated following re-segmentation in 2016.

7

Data source: Dealogic for the period covering 1 January to 31 December 2022.

 

Q422 Performance highlights1:

 

·

Attributable profit was £1.0bn and RoTE was 8.9% with profit before impairment of £1.8bn, up 29% year-on-year with positive cost: income jaws of 6%

·

Group income was £5.8bn, up 12% year-on-year including the benefit from FX, with strong performances in Barclays UK and CC&P. Within CIB, strong performances in Global Markets and Transaction banking were more than offset by reduced income in Investment Banking and Corporate Lending

·

Group operating expenses were £4.0bn, up 6% year-on-year, reflecting the impact of FX, inflation and investment in the business

·

Credit impairment charges were £0.5bn with an LLR of 49bps. The deteriorating macroeconomic forecast resulted in an increased charge, partially offset by utilising economic uncertainty PMAs

 

Outlook:

 

·

Returns: targeting RoTE of greater than 10% in 2023

·

Income: diversified income streams continue to position the Group well for the current economic and market environment including higher interest rates. In 2023, Barclays UK net interest margin (NIM) is expected to be greater than 3.20%2

·

Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards the Group's medium-term target of below 60%

·

Impairment: expect an LLR of 50-60bps in 2023, based on the current macroeconomic outlook

·

Capital: expect to operate within the CET1 ratio target range of 13-14%

·

Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with buybacks as appropriate

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

2

Assumes the UK bank rate peaks at 4.25% in 2023.

 

Barclays Group results

Year ended

Three months ended

31.12.22

Restated1

31.12.21

31.12.22

Restated1

31.12.21

£m

£m

% Change

£m

£m

% Change

Barclays UK

7,259

6,536

11

1,970

1,699

16

Corporate and Investment Bank

13,368

12,334

8

2,576

2,632

(2)

Consumer, Cards and Payments

4,499

3,331

35

1,286

878

46

Barclays International

17,867

15,665

14

3,862

3,510

10

Head Office

(170)

(261)

35

(31)

(49)

37

Total income

24,956

21,940

14

5,801

5,160

12

Operating costs

(14,957)

(14,092)

(6)

(3,748)

(3,514)

(7)

UK bank levy

(176)

(170)

(4)

(176)

(170)

(4)

Litigation and conduct

(1,597)

(397)

(79)

(92)

14

Total operating expenses

(16,730)

(14,659)

(14)

(4,003)

(3,776)

(6)

Other net income

6

260

(98)

10

13

(23)

Profit before impairment

8,232

7,541

9

1,808

1,397

29

Credit impairment (charges)/releases

(1,220)

653

(498)

31

Profit before tax

7,012

8,194

(14)

1,310

1,428

(8)

Tax (charge)/credit

(1,039)

(1,138)

9

33

(104)

Profit after tax

5,973

7,056

(15)

1,343

1,324

1

Non-controlling interests

(45)

(47)

4

(22)

(27)

19

Other equity instrument holders

(905)

(804)

(13)

(285)

(218)

(31)

Attributable profit

5,023

6,205

(19)

1,036

1,079

(4)

Performance measures

Return on average tangible shareholders' equity

10.4%

13.1%

8.9%

9.0%

Average tangible shareholders' equity (£bn)

48.3

47.3

46.7

48.0

Cost: income ratio

67%

67%

69%

73%

Loan loss rate (bps)

30

(18)

49

(3)

Basic earnings per share

30.8p

36.5p

6.5p

6.4p

Dividend per share

7.25p

6.0p

Share buyback announced (£m)

1,000

1,500

Total payout equivalent per share

c.13.4p

15.0p

Basic weighted average number of shares (m)

16,333

16,985

(4)

15,828

16,985

(7)

Period end number of shares (m)

15,871

16,752

(5)

15,871

16,752

(5)

 

As at 31.12.22

As at 30.09.22

Restated

As at 31.12.211

Balance sheet and capital management2

£bn

£bn

£bn

Loans and advances at amortised cost

398.8

413.7

361.5

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.6%

Total assets

1,513.7

1,726.9

1,384.3

Deposits at amortised cost

545.8

574.4

519.4

Tangible net asset value per share

295p

286p

291p

Common equity tier 1 ratio

13.9%

13.8%

15.1%

Common equity tier 1 capital

46.9

48.6

47.3

Risk weighted assets

336.5

350.8

314.1

UK leverage ratio

5.3%

5.0%

5.2%

UK leverage exposure

1,130.0

1,232.1

1,137.9

Average UK leverage ratio

4.8%

4.8%

4.9%

Average UK leverage exposure

1,281.0

1,259.6

1,229.0

Funding and liquidity

Group liquidity pool (£bn)

318

326

291

Liquidity coverage ratio

165%

151%

168%

Net stable funding ratio3

137%

Loan: deposit ratio

73%

72%

70%

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

2

Refer to pages 54 to 62 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated.

3

Represents average of the last four spot quarter end positions.

 

Reconciliation of financial results excluding the impact of the Over-issuance of Securities

 

Year ended 31.12.22

Restated1

Year ended 31.12.21

Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities

Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities

£m

£m

£m

£m

£m

£m

% Change

Barclays UK

7,259

-

7,259

6,536

-

6,536

11

Corporate and Investment Bank

13,368

292

13,076

12,334

-

12,334

6

Consumer, Cards and Payments

4,499

-

4,499

3,331

-

3,331

35

Barclays International

17,867

292

17,575

15,665

-

15,665

12

Head Office

(170)

-

(170)

(261)

-

(261)

35

Total income

24,956

292

24,664

21,940

-

21,940

12

Operating costs

(14,957)

-

(14,957)

(14,092)

-

(14,092)

(6)

UK bank levy

(176)

-

(176)

(170)

-

(170)

(4)

Litigation and conduct

(1,597)

(966)

(631)

(397)

(220)

(177)

Total operating expenses

(16,730)

(966)

(15,764)

(14,659)

(220)

(14,439)

(9)

Other net income

6

-

6

260

-

260

(98)

Profit before impairment

8,232

(674)

8,906

7,541

(220)

7,761

15

Credit impairment (charges)/releases

(1,220)

-

(1,220)

653

-

653

Profit before tax

7,012

(674)

7,686

8,194

(220)

8,414

(9)

Attributable profit

5,023

(552)

5,575

6,205

(170)

6,375

(13)

£bn

£bn

£bn

£bn

Average tangible shareholders' equity

48.3

48.3

47.3

47.3

Return on average tangible shareholders' equity

10.4%

11.6%

13.1%

13.5%

Three months ended 31.12.22

Restated1

Three months ended 31.12.21

Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities

Statutory

Impact of the Over-issuance of Securities

Excluding impact of the Over-issuance of Securities

£m

£m

£m

£m

£m

£m

% Change

Barclays UK

1,970

-

1,970

1,699

-

1,699

16

Corporate and Investment Bank

2,576

-

2,576

2,632

-

2,632

(2)

Consumer, Cards and Payments

1,286

-

1,286

878

-

878

46

Barclays International

3,862

-

3,862

3,510

-

3,510

10

Head Office

(31)

-

(31)

(49)

-

(49)

37

Total income

5,801

-

5,801

5,160

-

5,160

12

Operating costs

(3,748)

-

(3,748)

(3,514)

-

(3,514)

(7)

UK bank levy

(176)

-

(176)

(170)

-

(170)

(4)

Litigation and conduct

(79)

-

(79)

(92)

(46)

(46)

(72)

Total operating expenses

(4,003)

-

(4,003)

(3,776)

(46)

(3,730)

(7)

Other net income

10

-

10

13

-

13

(23)

Profit before impairment

1,808

-

1,808

1,397

(46)

1,443

25

Credit impairment (charges)/releases

(498)

-

(498)

31

-

31

Profit before tax

1,310

-

1,310

1,428

(46)

1,474

(11)

Attributable profit

1,036

-

1,036

1,079

(38)

1,117

(7)

£bn

£bn

£bn

£bn

Average tangible shareholders' equity

46.7

46.7

48.0

48.0

Return on average tangible shareholders' equity

8.9%

8.9%

9.0%

9.3%

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Group Finance Director's Review

 

2022 Group performance1

 

·

Barclays delivered a profit before tax of £7,012m (2021: £8,194m), RoTE of 10.4% (2021: 13.1%) and earnings per share (EPS) of 30.8p (2021: 36.5p)

·

The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The 10% appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses

·

Group income increased to £24,956m (2021: £21,940m)

-

Excluding the income benefit of £292m relating to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of Securities, total Group income was £24,664m, up 12% year-on-year

·

Group operating expenses increased to £16,730m (2021: £14,659m) mainly due to higher litigation and conduct charges:

-

Group operating expenses excluding litigation and conduct charges increased 6% to £15,133m, reflecting the impact of inflation and the appreciation of average USD against GBP

-

Litigation and conduct charges were £1,597m (2021: £397m) including £966m from the Over-issuance of Securities

·

Credit impairment charges were £1,220m (2021: £653m net release). The increase in charges reflect macroeconomic deterioration and a gradual increase in delinquencies, partially offset by the utilisation of macroeconomic uncertainty PMAs and the release of COVID-19 related adjustments informed by refreshed scenarios. Total coverage ratio decreased to 1.4% (December 2021: 1.6%) driven by changes in portfolio mix and write-offs. Coverage levels remain strong

·

The effective tax rate (ETR) was 14.8% (2021: 13.9%). The tax charge included a £346m re-measurement of the Group's UK deferred tax assets (DTAs) due to the enactment of legislation to reduce the UK banking surcharge rate. Excluding this DTAs downward re-measurement, the ETR was 9.9%, reflecting tax benefits in the current year, primarily arising from tax relief related to government bonds linked to the high prevailing rate of inflation in 2022, as well as beneficial adjustments in respect of prior years

·

Attributable profit was £5,023m (2021: £6,205m)

·

Total assets increased to £1,513.7bn (December 2021: £1,384.3bn) reflecting higher levels of activity as we supported our clients through a period of market volatility, growth in customer lending, and appreciation of USD against GBP

·

TNAV per share increased to 295p (December 2021: 291p) with EPS of 30.8p and currency movements partially offset by net negative reserve movements due to higher interest rates, primarily in the cash flow hedging reserve

 

Capital distributions

 

·

Barclays intends to pay a 2022 full year dividend of 5.0p per share, taking the total dividend for 2022 to 7.25p per share (2021: 6.0p). Barclays also intends to initiate a share buyback of up to £0.5bn, bringing the total share buybacks announced in relation to 2022 to £1.0bn and total capital return equivalent to c.13.4p per share

·

Barclays is committed to maintaining an appropriate balance between delivering attractive total cash returns to shareholders, investment in the business and maintaining a strong capital position. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividends as appropriate, including with share buybacks

·

Dividends will continue to be paid semi-annually

 

Group capital and leverage1

 

·

The reported CET1 ratio decreased by c.120bps to 13.9% (December 2021: 15.1%) as RWAs increased by £22.4bn to £336.5bn and CET1 capital decreased by £0.4bn to £46.9bn

-

c.150bps increase from 2022 attributable profit

-

c.80bps returned to shareholders including the 2.25p half year dividend paid in September 2022, £1.5bn of share buybacks announced with FY21 and H122 results and a FY22 dividend accrual

-

c.80bps reduction due to the impact of regulatory change on 1 January 2022 as CET1 capital decreased £1.7bn and RWAs increased £6.6bn

-

c.70bps reduction from decreases in the fair value of the bond portfolio through other comprehensive income and other capital deductions

-

c.40bps reduction due to pension contributions, including the accelerated cash settlement to the UK Retirement Fund (UKRF) of earlier deficit reduction contributions and deficit reduction payments made in 2022

-

A £14.1bn increase in RWAs as a result of foreign exchange movements was broadly offset by a £2bn increase in the currency translation reserve

·

The UK leverage ratio increased to 5.3% (December 2021: 5.2%) primarily due to a decrease in the leverage exposure of £7.9bn to £1,130.0bn and an increase in Tier 1 Capital of £0.6bn to £60.1bn

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Group funding and liquidity

 

·

The liquidity pool was £318bn (December 2021: £291bn) and the liquidity coverage ratio (LCR) remained significantly above the 100% regulatory requirement at 165% (December 2021: 168%), equivalent to a surplus of £117bn (December 2021: £116bn). The increase in the liquidity pool over the year was driven by continued deposit growth and an increase in wholesale funding, partly offset by an increase in business funding consumption. An increase in net stress outflows and trapped liquidity within Barclays' subsidiaries led to a modest reduction in the LCR ratio. The Net Stable Funding Ratio (NSFR) (average of last four quarter ends) was 137%, which represents a £155bn surplus above the 100% regulatory requirement

·

Wholesale funding outstanding, excluding repurchase agreements, was £184.0bn (December 2021: £167.5bn). The Group issued £15.3bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (BPLC) (the Parent company) in 2022. The Group has a strong MREL position with a ratio of 33.5% of RWAs, which is in excess of the 28.9% regulatory requirement excluding a confidential, institution specific Prudential Regulation Authority (PRA) buffer

 

Other matters

 

·

Over-issuance of Securities: Barclays recognised a net attributable loss of £0.6bn in 2022 (£nil in Q422, £0.7bn total loss including 2021). This included a monetary penalty of $200m (£165m1) following the resolution of the SEC's investigation of BPLC and BBPLC relating to the Over-issuance of Securities

As previously disclosed, Barclays has a contingent liability in relation to current and potential private civil claims and other potential enforcement actions relating to the Over-issuance of Securities. For further details see Restatement of financial statements (Note 1a) in the BPLC 2022 Annual Report on page 428.

·

SEC and Commodity and Futures Trading Commission (CFTC) devices investigation: in Q322, the SEC and CFTC announced the final settlement terms relating to their investigations of compliance with record-keeping obligations in connection with business-related communications over unapproved electronic messaging platforms. Under these settlements, BBPLC and Barclays Capital Inc. paid a combined $125m (£103m1) civil monetary penalty to the SEC and a $75m (£62m1) civil monetary penalty to the CFTC

·

Legacy Loan Portfolio: a customer remediation provision of £282m was recognised during 2022, relating to a legacy timeshare loan portfolio brokered by Azure Services Limited and other legacy loan portfolios

·

Financial Conduct Authority (FCA) proceedings: a provision of £50m was recognised in Q322 in relation to the FCA investigation into disclosure-related matters arising out of BPLC's June and November 2008 capital raisings

·

Gap portfolio acquisition: in Q222, Barclays completed the acquisition of a US credit card portfolio of $3.3bn (£2.7bn2) of receivables, in partnership with Gap Inc.

·

Kensington Mortgage Company (KMC) acquisition: in Q222, BPLC announced that Barclays Bank UK PLC had agreed to acquire UK specialist mortgage lender KMC and a portfolio of UK mortgages. Regulatory approval has been obtained and the transaction is now expected to complete in Q123

·

Absa Group Limited (Absa) sale: during 2022 Barclays fully disposed of its shareholding in Absa, raising aggregate gross sale proceeds of ZAR 21.0bn (c.£1.1bn3)

·

UK Corporation Tax: an increase in the UK Corporation Tax rate from 19% to 25% was enacted in 2021 and a reduction in the UK banking surcharge from 8% to 3% was enacted in 2022, both to be effective from 1 April 2023. The future statutory tax rate applied to UK banking profits will therefore be 28% from 1 April 2023

 

Group targets

 

Barclays continues to target the following over the medium-term:

·

Returns: RoTE of greater than 10%

·

Cost efficiency: cost: income ratio below 60%

·

Capital adequacy: CET1 ratio in the range of 13-14%

 

Anna Cross, Group Finance Director

 

1

Exchange rate GBP/USD 1.22 as at 30 June 2022.

2

Exchange rate GBP/USD 1.22 as at 17 June 2022.

3

On 21 April 2022, ZAR 10.3bn at exchange rate GBP/ZAR 20.04 and on 1 September 2022, ZAR 10.7bn at exchange rate GBP/ZAR 19.93.

 

Results by Business

 

Barclays UK

Year ended

Three months ended

31.12.22

31.12.21

31.12.22

31.12.21

Income statement information

£m

£m

% Change

£m

£m

% Change

Net interest income

5,893

5,202

13

1,600

1,313

22

Net fee, commission and other income

1,366

1,334

2

370

386

(4)

Total income

7,259

6,536

11

1,970

1,699

16

Operating costs

(4,260)

(4,357)

2

(1,108)

(1,202)

8

UK bank levy

(26)

(36)

28

(26)

(36)

28

Litigation and conduct

(41)

(37)

(11)

(13)

(5)

Total operating expenses

(4,327)

(4,430)

2

(1,147)

(1,243)

8

Other net income/(expenses)

-

-

1

(1)

Profit before impairment

2,932

2,106

39

824

455

81

Credit impairment (charges)/releases

(286)

365

(157)

59

Profit before tax

2,646

2,471

7

667

514

30

Attributable profit

1,877

1,756

7

474

420

13

Performance measures

Return on average allocated tangible equity

18.7%

17.6%

18.7%

16.8%

Average allocated tangible equity (£bn)

10.0

10.0

10.2

10.0

Cost: income ratio

60%

68%

58%

73%

Loan loss rate (bps)

13

(16)

27

(10)

Net interest margin

2.86%

2.52%

3.10%

2.49%

Key facts

UK mortgage balances (£bn)

162.2

158.1

Mortgage gross lending flow (£bn)

30.3

33.9

Average loan to value of mortgage portfolio1

50%

51%

Average loan to value of new mortgage lending1

68%

70%

Number of branches

481

666

Mobile banking active customers

10.5m

9.7m

30 day arrears rate - Barclaycard Consumer UK

0.9%

1.0%

Balance sheet information

£bn

£bn

Loans and advances to customers at amortised cost

205.1

208.8

Total assets

313.2

321.2

Customer deposits at amortised cost

258.0

260.6

Loan: deposit ratio

87%

85%

Risk weighted assets

73.1

72.3

Period end allocated tangible equity

10.1

10.0

 

1

Average loan to value (LTV) of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans portfolio.

 

Analysis of Barclays UK

Year ended

Three months ended

31.12.22

31.12.21

31.12.22

31.12.21

Analysis of total income

£m

£m

% Change

£m

£m

% Change

Personal Banking

4,540

3,883

17

1,229

983

25

Barclaycard Consumer UK

1,093

1,250

(13)

269

352

(24)

Business Banking

1,626

1,403

16

472

364

30

Total income

7,259

6,536

11

1,970

1,699

16

Analysis of credit impairment (charges)/releases

Personal Banking

(167)

28

(120)

8

Barclaycard Consumer UK

30

404

(93)

(12)

114

Business Banking

(149)

(67)

(25)

(63)

60

Total credit impairment (charges)/releases

(286)

365

 

(157)

59

 

Analysis of loans and advances to customers at amortised cost

£bn

£bn

Personal Banking

169.7

165.4

Barclaycard Consumer UK

9.2

8.7

Business Banking

26.2

34.7

Total loans and advances to customers at amortised cost

205.1

208.8

Analysis of customer deposits at amortised cost

Personal Banking

195.6

196.4

Barclaycard Consumer UK

-

-

Business Banking

62.4

64.2

Total customer deposits at amortised cost

258.0

260.6

 

Barclays UK delivered a RoTE of 18.7% (2021: 17.6%) as the transformation into a next generation, digitised consumer bank drove strong returns and cost efficiencies, which combined with rising interest rates contributed to a cost: income ratio of 60% (2021: 68%). Barclays UK continues to support customers through affordability pressures.

 

2022 compared to 2021

 

Income statement

 

·

Profit before tax increased to £2,646m (2021: £2,471m), with benefits from the rising rate environment in the UK more than offsetting the non-recurrence of a prior year credit impairment release

·

Total income increased 11% to £7,259m. Net interest income increased 13% to £5,893m with a NIM of 2.86% (2021: 2.52%) primarily driven by the rising interest rate environment in the UK. Net fee, commission and other income increased 2% to £1,366m

-

Personal Banking income increased 17% to £4,540m, driven by rising interest rates, partially offset by mortgage margin compression

-

Barclaycard Consumer UK income decreased 13% to £1,093m as higher customer spend volumes were more than offset by lower interest earning lending (IEL) balances following repayments and ongoing prudent risk management

-

Business Banking income increased 16% to £1,626m driven by rising interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending income as repayments continue

·

Total operating expenses decreased 2% to £4,327m driven by efficiency savings more than offsetting the impact of inflation

·

Credit impairment charges were £286m (2021: £365m net release). The charges reflect an updated macroeconomic scenario together with a partial return to more normalised levels of customer behaviour. This is partially offset from the release of COVID-19 related adjustments as performance stabilises at or below pre-pandemic levels. As at 31 December 2022, UK cards 30 and 90 day arrears remain at 0.9% (Q421: 1.0%) and 0.2% (Q421: 0.2%) respectively1. The UK cards business is supported by a total coverage ratio of 7.6% (December 2021: 12.8%). The UK cards coverage reflects revised recovery expectations under the ongoing debt sale program and continued resilience in the underlying book. PMAs are in place for the anticipated stress arising from the cost-of-living crisis

 

Balance sheet

 

·

Loans and advances to customers at amortised cost decreased 2% to £205.1bn as £4.1bn of mortgage growth was more than offset by a £8.5bn decrease in Business Banking balances due to the repayment of government scheme lending and the yield curve impact from rising interest rates on the Education, Social Housing and Local Authority portfolio carrying value

·

Customer deposits at amortised cost remained broadly stable at £258.0bn (December 2021: £260.6bn), maintaining a strong loan: deposit ratio of 87% (December 2021: 85%)

·

RWAs remained broadly stable at £73.1bn (December 2021: £72.3bn)

 

1

As at 31 December 2019, UK cards 30 and 90 day arrears were 1.7% and 0.8% respectively.

 

Barclays International

Year ended

Three months ended

31.12.22

Restated1

31.12.21

31.12.22

Restated1

31.12.21

Income statement information

£m

£m

% Change

£m

£m

% Change

Net interest income

4,927

3,263

51

1,465

955

53

Net trading income

7,709

5,693

35

1,169

789

48

Net fee, commission and other income

5,231

6,709

(22)

1,228

1,766

(30)

Total income

17,867

15,665

14

3,862

3,510

10

Operating costs

(10,361)

(9,076)

(14)

(2,543)

(2,160)

(18)

UK bank levy

(133)

(134)

1

(133)

(134)

1

Litigation and conduct

(1,503)

(345)

(67)

(84)

20

Total operating expenses

(11,997)

(9,555)

(26)

(2,743)

(2,378)

(15)

Other net income

28

40

(30)

5

3

67

Profit before impairment

5,898

6,150

(4)

1,124

1,135

(1)

Credit impairment (charges)/releases

(933)

288

(328)

(23)

Profit before tax

4,965

6,438

(23)

796

1,112

(28)

Attributable profit

3,844

4,647

(17)

625

818

(24)

Performance measures

Return on average allocated tangible equity

10.2%

14.4%

6.4%

9.9%

Average allocated tangible equity (£bn)

37.6

32.4

38.9

32.9

Cost: income ratio

67%

61%

71%

68%

Loan loss rate (bps)

54

(21)

75

7

Net interest margin

5.02 %

4.01 %

5.71%

4.14 %

Balance sheet information

£bn

£bn

Loans and advances to customers at amortised cost

133.7

106.4

Loans and advances to banks at amortised cost

8.7

8.4

Debt securities at amortised cost

27.2

19.0

Loans and advances at amortised cost

169.6

133.8

Trading portfolio assets

133.8

146.9

Derivative financial instrument assets

301.7

261.5

Financial assets at fair value through the income statement

210.5

188.2

Cash collateral and settlement balances

107.7

88.1

Other assets

258.0

225.6

Total assets

1,181.3

1,044.1

Deposits at amortised cost

287.6

258.8

Derivative financial instrument liabilities

288.9

256.4

Loan: deposit ratio

59%

52 %

Risk weighted assets

254.8

230.9

Period end allocated tangible equity

36.8

33.2

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information

 

Analysis of Barclays International

Corporate and Investment Bank

Year ended

Three months ended

31.12.22

Restated1

31.12.21

31.12.22

Restated1

31.12.21

Income statement information

£m

£m

% Change

£m

£m

% Change

Net interest income

1,949

1,351

44

548

432

27

Net trading income

7,733

5,652

37

1,201

774

55

Net fee, commission and other income

3,686

5,331

(31)

827

1,426

(42)

Total income

13,368

12,334

8

2,576

2,632

(2)

Operating costs

(7,630)

(6,818)

(12)

(1,796)

(1,562)

(15)

UK bank levy

(126)

(128)

2

(126)

(128)

2

Litigation and conduct

(1,189)

(237)

(55)

(59)

7

Total operating expenses

(8,945)

(7,183)

(25)

(1,977)

(1,749)

(13)

Other net income

2

2

2

1

Profit before impairment

4,425

5,153

(14)

601

884

(32)

Credit impairment (charges)/releases

(119)

473

(41)

73

Profit before tax

4,306

5,626

(23)

560

957

(41)

Attributable profit

3,364

4,032

(17)

454

695

(35)

Performance measures

Return on average allocated tangible equity

10.2%

14.3%

5.4%

9.7%

Average allocated tangible equity (£bn)

32.8

28.3

33.7

28.7

Cost: income ratio

67%

58%

77%

66%

Loan loss rate (bps)

9

(47)

13

(29)

Balance sheet information

£bn

£bn

Loans and advances to customers at amortised cost

90.5

73.4

Loans and advances to banks at amortised cost

8.1

7.6

Debt securities at amortised cost

27.2

19.0

Loans and advances at amortised cost

125.8

100.0

Trading portfolio assets

133.7

146.7

Derivative financial instrument assets

301.6

261.5

Financial assets at fair value through the income statement

210.5

188.1

Cash collateral and settlement balances

106.9

87.2

Other assets

222.6

195.8

Total assets

1,101.1

979.3

Deposits at amortised cost

205.8

189.4

Derivative financial instrument liabilities

288.9

256.4

Risk weighted assets

215.9

200.7

Analysis of total income

£m

£m

% Change

£m

£m

% Change

FICC

5,695

3,448

65

976

546

79

Equities

3,149

2,967

6

440

501

(12)

Global Markets

8,844

6,415

38

1,416

1,047

35

Advisory

768

921

(17)

197

287

(31)

Equity capital markets

166

813

(80)

40

158

(75)

Debt capital markets

1,281

1,925

(33)

243

511

(52)

Investment Banking fees

2,215

3,659

(39)

480

956

(50)

Corporate lending

(231)

588

(128)

176

Transaction banking

2,540

1,672

52

808

453

78

Corporate

2,309

2,260

2

680

629

8

Total income

13,368

12,334

8

2,576

2,632

(2)

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information

 

Analysis of Barclays International

Consumer, Cards and Payments

Year ended

Three months ended

31.12.22

31.12.21

31.12.22

31.12.21

Income statement information

£m

£m

% Change

£m

£m

% Change

Net interest income

2,979

1,912

56

918

522

76

Net fee, commission, trading and other income

1,520

1,419

7

368

356

3

Total income

4,499

3,331

35

1,286

878

46

Operating costs

(2,731)

(2,258)

(21)

(747)

(598)

(25)

UK bank levy

(7)

(6)

(17)

(7)

(6)

(17)

Litigation and conduct

(314)

(108)

(12)

(25)

52

Total operating expenses

(3,052)

(2,372)

(29)

(766)

(629)

(22)

Other net income

26

38

(32)

3

2

50

Profit before impairment

1,473

997

48

523

251

 

Credit impairment charges

(814)

(185)

(287)

(96)

Profit before tax

659

812

(19)

236

155

52

Attributable profit

480

615

(22)

171

123

39

Performance measures

Return on average allocated tangible equity

10.0%

15.0%

13.0%

11.7%

Average allocated tangible equity (£bn)

4.8

4.1

5.2

4.2

Cost: income ratio

68%

71%

60%

72%

Loan loss rate (bps)

175

51

245

105

Key facts

US cards 30 day arrears rate

2.2%

1.6%

US cards customer FICO score distribution

11%

10%

>660

89%

90%

Total number of payments clients

395k

380k

Value of payments processed (£bn)1

307

277

Balance sheet information

£bn

£bn

Loans and advances to customers at amortised cost

43.2

33.0

Total assets

80.2

64.8

Deposits at amortised cost

81.8

69.4

Risk weighted assets

38.9

30.2

Analysis of total income

£m

£m

% Change

£m

£m

% Change

International Cards and Consumer Bank

2,913

2,092

39

860

552

56

Private Bank

1,014

781

30

285

200

43

Payments

572

458

25

141

126

12

Total income

4,499

3,331

35

1,286

878

46

 

1

Includes £296bn (2021: £270bn) of merchant acquiring payments.

 

Barclays International delivered a RoTE of 10.2% (2021: 14.4%) reflecting the benefits of income diversification and continued investment in sustainable growth, partially offset by the net impact of the Over-issuance of Securities in the CIB. CC&P performance reflected continued income momentum, investment for growth and a provision for customer remediation costs relating to legacy loan portfolios.

 

2022 compared to 2021

 

Income statement1

 

·

Profit before tax decreased 23% to £4,965m with a RoTE of 10.2% (2021: 14.4%), reflecting a RoTE of 10.2% (2021: 14.3%) in CIB and 10.0% (2021: 15.0%) in CC&P

-

Excluding the impact of the Over-issuance of Securities, CIB RoTE was 12.0%

·

Barclays International has a diverse income profile across businesses and geographies including a significant presence in the US. The 10% appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges, total operating expenses and RWAs

·

Total income increased to £17,867m (2021: £15,665m)

-

CIB income increased 8% to £13,368m

-

Global Markets income increased 38% to £8,844m representing the best full year for both Global Markets and FICC on a comparable basis2. FICC income increased 65% to £5,695m, mainly in macro, reflecting higher levels of activity as we supported our clients through a period of market volatility. Equities income of £3,149m (2021: £2,967m) included £292m of income related to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of Securities

-

Investment Banking fees decreased 39% to £2,215m due to the reduced fee pool, particularly in Equity and Debt capital markets3

-

Within Corporate, Transaction banking income increased 52% to £2,540m driven by improved margins and growth in deposits, and higher fee income. Corporate lending income reflected fair value losses on leverage finance lending of c.£335m net of mark to market gains on related hedges, of which c.£85m was recognised in Q422, and higher costs of hedging and credit protection

-

CC&P income increased 35% to £4,499m

-

International Cards and Consumer Bank income increased 39% to £2,913m reflecting higher cards balances, including the Gap portfolio acquisition, partially offset by higher customer acquisition costs

-

Private Bank income increased 30% to £1,014m, reflecting client balance growth and improved margins partially offset by the non-recurrence of a property sale gain in the prior year

-

Payments income increased 25% to £572m driven by turnover growth from the easing of lockdown restrictions

·

Total operating expenses increased 26% to £11,997m

-

CIB total operating expenses increased 25% to £8,945m. Operating expenses excluding litigation and conduct charges increased 12% to £7,756m driven by continued investment in talent and technology, and the impact of inflation. Litigation and conduct charges were £1,189m (2021: £237m) including £966m from the Over-issuance of Securities and £165m relating to the Devices Settlements4

-

CC&P total operating expenses increased 29% to £3,052m. Operating expenses excluding litigation and conduct charges increased 21% to £2,738m, including higher investment spend reflecting an increase in marketing and partnership costs. Litigation and conduct charges were £314m (2021: £108m) mainly driven by customer remediation costs relating to legacy loan portfolios

·

Credit impairment charges were £933m (2021: £288m net release) driven by a deteriorating macroeconomic forecast

-

CIB credit impairment charges of £119m (2021: £473m net release) were driven by a net increase in modelled impairment and single name charges partially offset by the benefit of credit protection

-

CC&P credit impairment charges increased to £814m (2021: £185m), driven by higher balances in US cards, including the day one impact of acquiring the Gap portfolio, macroeconomic deterioration and a gradual increase in delinquencies, partially offset by the utilisation of economic uncertainty PMAs and the release of COVID-19 related adjustments informed by refreshed macroeconomic scenarios. As at 31 December 2022, US cards 30 and 90 day arrears remain below pre-pandemic levels at 2.2% (Q421: 1.6%) and 1.2% (Q421: 0.8%) respectively5. The US cards business is supported by a total coverage ratio of 8.1% (December 2021: 10.6%)

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

2

Period covering 2014-2016. Pre 2014 data was not restated following re-segmentation in 2016.

3

Data source: Dealogic for the period covering 1 January to 31 December 2022.

4

Refers to the settlements with the SEC and CFTC in connection with their investigations of the use of unauthorised devices for business communications. See Other matters on page 7.

5

As at 31 December 2019, US cards 30 and 90 days arrears were 2.7% and 1.4% respectively.

 

Balance sheet

 

·

Loans and advances at amortised cost increased £35.8bn to £169.6bn due to increased lending to customers across CIB and CC&P, inclusive of the Gap portfolio acquisition and appreciation of USD against GBP, and increased investment in debt securities

·

Trading portfolio assets decreased £13.1bn to £133.8bn due to a reduction in equity securities as clients repositioned their demand, partially offset by increased trading activity in debt securities

·

Derivative assets and liabilities increased £40.2bn and £32.5bn respectively to £301.7bn and £288.9bn driven by market volatility and increased activity

·

Financial assets at fair value through the income statement increased £22.3bn to £210.5bn driven by increased reverse repurchase activity

·

Deposits at amortised cost increased £28.8bn to £287.6bn primarily due to growth in Corporate deposits and an increase in short-term money market deposits

·

RWAs increased to £254.8bn (December 2021: £230.9bn) mainly resulting from the impact of the appreciation of USD against GBP, regulatory changes and higher CC&P balances including the Gap portfolio

 

Head Office

Year ended

Three months ended

31.12.22

31.12.21

31.12.22

31.12.21

Income statement information

£m

£m

% Change

£m

£m

% Change

Net interest income

(248)

(392)

37

(324)

(38)

Net fee, commission and other income

78

131

(40)

293

(11)

Total income

(170)

(261)

35

(31)

(49)

37

Operating costs

(336)

(659)

49

(97)

(152)

36

UK bank levy

(17)

-

(17)

-

Litigation and conduct

(53)

(15)

1

(3)

Total operating expenses

(406)

(674)

40

(113)

(155)

27

Other net (expenses)/income

(22)

220

4

11

(64)

Loss before impairment

(598)

(715)

16

(140)

(193)

27

Credit impairment charges

(1)

-

(13)

(5)

Loss before tax

(599)

(715)

16

(153)

(198)

23

Attributable loss

(698)

(198)

(63)

(159)

60

Performance measures1

Average allocated tangible equity (£bn)

0.7

5.0

(2.4)

5.1

Balance sheet information1

£bn

£bn

Total assets

19.2

19.0

Risk weighted assets

8.6

11.0

Period end allocated tangible equity

(0.2)

5.5

 

2022 compared to 2021

 

Income statement

 

·

Loss before tax was £599m (2021: £715m)

·

Total income was an expense of £170m (2021: £261m) primarily reflecting treasury items, funding costs on legacy capital instruments and mark-to-market losses on legacy investments, partially offset by hedge accounting gains. Additionally, there was a £74m loss on sale arising from disposals of Barclays' equity stake in Absa, and a £72m interest expense that became payable to a US tax authority upon the resolution of historical tax issues. This was partially offset by a gain of £86m from the sale and leaseback of UK data centres and the receipt of £30m of dividends from Absa prior to disposal

·

Total operating expenses reduced to £406m (2021: £674m) reflecting the non-recurrence of the £266m structural cost action charge taken as part of the real estate review in June 2021

·

Other net income was an expense of £22m (2021: £220m income) driven by a fair value loss on investments held by the Business Growth Fund in which Barclays has an associate interest

 

Balance sheet

·

RWAs reduced to £8.6bn (December 2021: £11.0bn) reflecting the disposals of Barclays' equity stake in Absa in April 2022 and September 2022

 

1

2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Quarterly Results Summary

 

Barclays Group

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

2,741

3,068

2,422

2,341

2,230

1,940

2,052

1,851

Net fee, commission and other income

3,060

2,883

4,286

4,155

2,930

3,525

3,363

4,049

Total income

5,801

5,951

6,708

6,496

5,160

5,465

5,415

5,900

Operating costs

(3,748)

(3,939)

(3,682)

(3,588)

(3,514)

(3,446)

(3,587)

(3,545)

UK bank levy

(176)

-

-

-

(170)

-

-

-

Litigation and conduct

(79)

339

(1,334)

(523)

(92)

(129)

(143)

(33)

Total operating expenses

(4,003)

(3,600)

(5,016)

(4,111)

(3,776)

(3,575)

(3,730)

(3,578)

Other net income/(expenses)

10

(1)

7

(10)

13

94

21

132

Profit before impairment

1,808

2,350

1,699

2,375

1,397

1,984

1,706

2,454

Credit impairment (charges)/releases

(498)

(381)

(200)

(141)

31

(120)

797

(55)

Profit before tax

1,310

1,969

1,499

2,234

1,428

1,864

2,503

2,399

Tax credit/(charge)

33

(249)

(209)

(614)

(104)

(292)

(246)

(496)

Profit after tax

1,343

1,720

1,290

1,620

1,324

1,572

2,257

1,903

Non-controlling interests

(22)

(2)

(20)

(1)

(27)

(1)

(15)

(4)

Other equity instrument holders

(285)

(206)

(199)

(215)

(218)

(197)

(194)

(195)

Attributable profit

1,036

1,512

1,071

1,404

1,079

1,374

2,048

1,704

Performance measures

Return on average tangible shareholders' equity

8.9%

12.5%

8.7%

11.5%

9.0%

11.4%

17.6%

14.7%

Average tangible shareholders' equity (£bn)

46.7

48.6

49.0

48.8

48.0

48.3

46.5

46.5

Cost: income ratio

69%

60%

75%

63%

73%

65%

69%

61%

Loan loss rate (bps)

49

36

20

15

(3)

13

(90)

6

Basic earnings per share

6.5p

9.4p

6.4p

8.4p

6.4p

8.0p

11.9p

9.9p

Basic weighted average number of shares (m)

15,828

16,148

16,684

16,682

16,985

17,062

17,140

17,293

Period end number of shares (m)

15,871

15,888

16,531

16,762

16,752

16,851

16,998

17,223

Balance sheet and capital management2

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

343.3

346.3

337.2

325.8

319.9

313.5

309.2

306.9

Loans and advances to banks at amortised cost

10.0

12.5

12.5

11.4

9.7

10.6

11.0

12.9

Debt securities at amortised cost

45.5

54.8

46.1

34.5

31.8

28.9

28.3

25.9

Loans and advances at amortised cost

398.8

413.7

395.8

371.7

361.5

353.0

348.5

345.8

Loans and advances at amortised cost impairment coverage ratio

1.4%

1.4%

1.4%

1.5%

1.6%

1.7%

1.8%

2.2%

Total assets

1,513.7

1,726.9

1,589.2

1,496.1

1,384.3

1,406.5

1,376.3

1,379.7

Deposits at amortised cost

545.8

574.4

568.7

546.5

519.4

510.2

500.9

498.8

Tangible net asset value per share

295p

286p

297p

294p

291p

286p

280p

267p

Common equity tier 1 ratio

13.9%

13.8%

13.6%

13.8%

15.1%

15.3%

15.0%

14.6%

Common equity tier 1 capital

46.9

48.6

46.7

45.3

47.3

47.2

46.2

45.9

Risk weighted assets

336.5

350.8

344.5

328.8

314.1

307.7

307.4

313.4

UK leverage ratio

5.3%

5.0%

5.1%

5.0%

5.2%

5.1%

5.0%

5.0%

UK leverage exposure

1,130.0

1,232.1

1,151.2

1,123.5

1,137.9

1,162.7

1,154.9

1,145.4

Average UK leverage ratio

4.8%

4.8%

4.7%

4.8%

4.9%

4.9%

4.8%

4.9%

Average UK leverage exposure

1,281.0

1,259.6

1,233.5

1,179.4

1,229.0

1,201.1

1,192.7

1,174.9

Funding and liquidity

Group liquidity pool (£bn)

318

326

343

320

291

293

291

290

Liquidity coverage ratio

165%

151%

156%

159%

168%

161%

162%

161%

Net stable funding ratio3

137%

Loan: deposit ratio

73%

72%

70%

68%

70%

69%

70%

69%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

2

Refer to pages 54 to 62 for further information on how capital, RWAs and leverage are calculated.

3

Represents average of the last four spot quarter end positions.

 

Quarterly Results by Business

 

Barclays UK

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,600

1,561

1,393

1,339

1,313

1,303

1,305

1,281

Net fee, commission and other income

370

355

331

310

386

335

318

295

Total income

1,970

1,916

1,724

1,649

1,699

1,638

1,623

1,576

Operating costs

(1,108)

(1,069)

(1,085)

(998)

(1,202)

(1,041)

(1,078)

(1,036)

UK bank levy

(26)

-

-

-

(36)

-

-

-

Litigation and conduct

(13)

(3)

(16)

(9)

(5)

(10)

(19)

(3)

Total operating expenses

(1,147)

(1,072)

(1,101)

(1,007)

(1,243)

(1,051)

(1,097)

(1,039)

Other net income/(expenses)

1

(1)

-

-

(1)

1

-

-

Profit before impairment

824

843

623

642

455

588

526

537

Credit impairment (charges)/releases

(157)

(81)

-

(48)

59

(137)

520

(77)

Profit before tax 

667

762

623

594

514

451

1,046

460

Attributable profit

474

549

458

396

420

317

721

298

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

205.1

205.1

205.9

207.3

208.8

208.6

207.8

205.7

Total assets

313.2

316.8

318.8

317.2

321.2

312.1

311.2

309.1

Customer deposits at amortised cost

258.0

261.0

261.5

260.3

260.6

256.8

255.5

247.5

Loan: deposit ratio

87%

86%

85%

85%

85%

86%

87%

88%

Risk weighted assets

73.1

73.2

72.2

72.7

72.3

73.2

72.2

72.7

Period end allocated tangible equity

10.1

10.1

9.9

10.1

10.0

10.0

9.9

10.0

Performance measures

Return on average allocated tangible equity

18.7%

22.1%

18.4%

15.6%

16.8%

12.7%

29.1%

12.0%

Average allocated tangible equity (£bn)

10.2

9.9

10.0

10.1

10.0

10.0

9.9

9.9

Cost: income ratio

58%

56%

64%

61%

73%

64%

68%

66%

Loan loss rate (bps)

27

14

-

9

(10)

24

(93)

14

Net interest margin

3.10%

3.01%

2.71%

2.62%

2.49%

2.49%

2.55%

2.54%

 

Analysis of Barclays UK

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

Personal Banking

1,229

1,212

1,077

1,022

983

990

987

923

Barclaycard Consumer UK

269

283

265

276

352

293

290

315

Business Banking

472

421

382

351

364

355

346

338

Total income

1,970

1,916

1,724

1,649

1,699

1,638

1,623

1,576

Analysis of credit impairment (charges)/releases

Personal Banking

(120)

(26)

(42)

21

8

(30)

72

(22)

Barclaycard Consumer UK

(12)

2

84

(44)

114

(108)

434

(36)

Business Banking

(25)

(57)

(42)

(25)

(63)

1

14

(19)

Total credit impairment (charges)/releases

(157)

(81)

-

(48)

59

(137)

520

(77)

Analysis of loans and advances to customers at amortised cost

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Personal Banking

169.7

168.7

167.1

166.5

165.4

164.6

162.4

160.4

Barclaycard Consumer UK

9.2

9.0

8.8

8.4

8.7

8.6

8.8

8.7

Business Banking

26.2

27.4

30.0

32.4

34.7

35.4

36.6

36.6

Total loans and advances to customers at amortised cost

205.1

205.1

205.9

207.3

208.8

208.6

207.8

205.7

Analysis of customer deposits at amortised cost

Personal Banking

195.6

197.3

197.0

196.6

196.4

193.3

191.0

186.0

Barclaycard Consumer UK

-

-

-

-

-

-

0.1

0.1

Business Banking

62.4

63.7

64.5

63.7

64.2

63.5

64.4

61.4

Total customer deposits at amortised cost

258.0

261.0

261.5

260.3

260.6

256.8

255.5

247.5

 

Barclays International

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

1,465

1,497

1,029

936

955

749

811

748

Net trading income

1,169

1,328

2,766

2,446

789

1,515

1,455

1,934

Net fee, commission and other income

1,228

1,240

1,321

1,442

1,766

1,673

1,553

1,717

Total income

3,862

4,065

5,116

4,824

3,510

3,937

3,819

4,399

Operating costs

(2,543)

(2,776)

(2,537)

(2,505)

(2,160)

(2,310)

(2,168)

(2,438)

UK bank levy

(133)

-

-

-

(134)

-

-

-

Litigation and conduct

(67)

396

(1,319)

(513)

(84)

(100)

(140)

(21)

Total operating expenses

(2,743)

(2,380)

(3,856)

(3,018)

(2,378)

(2,410)

(2,308)

(2,459)

Other net income

5

10

5

8

3

15

13

9

Profit before impairment

1,124

1,695

1,265

1,814

1,135

1,542

1,524

1,949

Credit impairment (charges)/releases

(328)

(295)

(209)

(101)

(23)

18

271

22

Profit before tax

796

1,400

1,056

1,713

1,112

1,560

1,795

1,971

Attributable profit

625

1,136

783

1,300

818

1,191

1,207

1,431

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

133.7

137.0

126.7

113.9

106.4

99.9

96.3

97.1

Loans and advances to banks at amortised cost

8.7

11.0

11.3

10.2

8.4

9.4

9.9

12.0

Debt securities at amortised cost

27.2

36.2

29.3

20.7

19.0

16.6

15.7

14.4

Loans and advances at amortised cost

169.6

184.2

167.3

144.8

133.8

125.9

121.9

123.5

Trading portfolio assets

133.8

126.3

126.9

134.1

146.9

144.8

147.1

131.1

Derivative financial instrument assets

301.7

415.7

343.5

288.8

261.5

257.0

255.4

269.4

Financial assets at fair value through the income statement

210.5

244.7

209.3

203.8

188.2

200.5

190.4

197.5

Cash collateral and settlement balances

107.7

163.3

128.5

132.0

88.1

115.9

108.5

109.7

Other assets

258.0

257.2

275.1

255.5

225.6

231.8

223.5

221.7

Total assets

1,181.3

1,391.4

1,250.6

1,159.0

1,044.1

1,075.9

1,046.8

1,052.9

Deposits at amortised cost

287.6

313.2

307.4

286.1

258.8

253.3

245.4

251.2

Derivative financial instrument liabilities

288.9

394.2

321.2

277.2

256.4

252.3

246.9

260.2

Loan: deposit ratio

59%

59%

54%

51%

52%

50%

50%

49%

Risk weighted assets

254.8

269.3

263.8

245.1

230.9

222.7

223.2

230.0

Period end allocated tangible equity

36.8

38.8

38.0

35.6

33.2

31.8

31.8

32.7

Performance measures

Return on average allocated tangible equity

6.4%

11.6%

8.4%

14.8%

9.9%

14.9%

14.9%

17.7%

Average allocated tangible equity (£bn)

38.9

39.1

37.3

35.1

32.9

31.8

32.4

32.3

Cost: income ratio

71%

59%

75%

63%

68%

61%

60%

56%

Loan loss rate (bps)

75

62

49

28

7

(6)

(87)

(7)

Net interest margin

5.71%

5.58%

4.52%

4.15%

4.14%

4.02%

3.96%

3.92%

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Analysis of Barclays International

Corporate and Investment Bank

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

548

606

410

385

432

279

370

270

Net trading income

1,201

1,344

2,738

2,450

774

1,467

1,494

1,917

Net fee, commission and other income

827

871

885

1,103

1,426

1,383

1,115

1,407

Total income

2,576

2,821

4,033

3,938

2,632

3,129

2,979

3,594

Operating costs

(1,796)

(2,043)

(1,870)

(1,921)

(1,562)

(1,747)

(1,623)

(1,886)

UK bank levy

(126)

-

-

-

(128)

-

-

-

Litigation and conduct

(55)

498

(1,314)

(318)

(59)

(99)

(78)

(1)

Total operating expenses

(1,977)

(1,545)

(3,184)

(2,239)

(1,749)

(1,846)

(1,701)

(1,887)

Other net income

2

-

-

-

1

-

-

1

Profit before impairment

601

1,276

849

1,699

884

1,283

1,278

1,708

Credit impairment (charges)/releases

(41)

(46)

(65)

33

73

128

229

43

Profit before tax

560

1,230

784

1,732

957

1,411

1,507

1,751

Attributable profit

454

1,015

579

1,316

695

1,085

989

1,263

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

90.5

93.6

86.5

79.5

73.4

68.3

66.3

68.5

Loans and advances to banks at amortised cost

8.1

10.2

10.0

9.4

7.6

8.9

9.0

11.4

Debt securities at amortised cost

27.2

36.2

29.3

20.7

19.0

16.6

15.7

14.4

Loans and advances at amortised cost

125.8

140.0

125.8

109.6

100.0

93.8

91.0

94.3

Trading portfolio assets

133.7

126.1

126.7

134.0

146.7

144.7

147.0

130.9

Derivative financial instruments assets

301.6

415.5

343.4

288.7

261.5

256.9

255.3

269.4

Financial assets at fair value through the income statement

210.5

244.6

209.2

203.8

188.1

200.4

190.3

197.3

Cash collateral and settlement balances

106.9

162.6

127.7

131.2

87.2

115.1

107.7

108.8

Other assets

222.6

220.6

237.2

222.5

195.8

200.4

192.5

190.8

Total assets

1,101.1

1,309.4

1,170.0

1,089.8

979.3

1,011.3

983.8

991.5

Deposits at amortised cost

205.8

229.5

229.5

214.7

189.4

185.8

178.2

185.2

Derivative financial instrument liabilities

288.9

394.2

321.2

277.1

256.4

252.2

246.8

260.2

Risk weighted assets

215.9

230.6

227.6

213.5

200.7

192.5

194.3

201.3

Performance measures

Return on average allocated tangible equity

5.4%

11.9%

7.1%

17.1%

9.7%

15.6%

14.0%

17.9%

Average allocated tangible equity (£bn)

33.7

34.0

32.7

30.8

28.7

27.8

28.4

28.2

Cost: income ratio

77%

55%

79%

57%

66%

59%

57%

53%

Loan loss rate (bps)

13

13

20

(12)

(29)

(54)

(100)

(18)

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

FICC

976

1,546

1,529

1,644

546

803

895

1,204

Equities

440

246

1,411

1,052

501

757

777

932

Global Markets

1,416

1,792

2,940

2,696

1,047

1,560

1,672

2,136

Advisory

197

150

236

185

287

253

218

163

Equity capital markets

40

42

37

47

158

186

226

243

Debt capital markets

243

341

281

416

511

532

429

453

Investment Banking fees

480

533

554

648

956

971

873

859

Corporate lending

(128)

(181)

(47)

125

176

168

38

206

Transaction banking

808

677

586

469

453

430

396

393

Corporate

680

496

539

594

629

598

434

599

Total income

2,576

2,821

4,033

3,938

2,632

3,129

2,979

3,594

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Analysis of Barclays International

Consumer, Cards and Payments

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

918

891

619

551

522

471

441

478

Net fee, commission, trading and other income

368

353

464

335

356

337

399

327

Total income

1,286

1,244

1,083

886

878

808

840

805

Operating costs

(747)

(733)

(667)

(584)

(598)

(563)

(545)

(552)

UK bank levy

(7)

-

-

-

(6)

-

-

-

Litigation and conduct

(12)

(102)

(5)

(195)

(25)

(1)

(62)

(20)

Total operating expenses

(766)

(835)

(672)

(779)

(629)

(564)

(607)

(572)

Other net income

3

10

5

8

2

15

13

8

Profit before impairment

523

419

416

115

251

259

246

241

Credit impairment (charges)/releases

(287)

(249)

(144)

(134)

(96)

(110)

42

(21)

Profit/(loss) before tax

236

170

272

(19)

155

149

288

220

Attributable profit/(loss)

171

121

204

(16)

123

106

218

168

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Loans and advances to customers at amortised cost

43.2

43.4

40.2

34.4

33.0

31.6

30.0

28.6

Total assets

80.2

82.0

80.6

69.2

64.8

64.6

63.0

61.4

Deposits at amortised cost

81.8

83.7

77.9

71.4

69.4

67.5

67.2

66.0

Risk weighted assets

38.9

38.7

36.2

31.6

30.2

30.2

29.0

28.8

Performance measures

Return on average allocated tangible equity

13.0%

9.5%

17.8%

(1.5)%

11.7%

10.5%

21.8%

16.5%

Average allocated tangible equity (£bn)

5.2

5.1

4.6

4.3

4.2

4.0

4.0

4.1

Cost: income ratio

60%

67%

62%

88%

72%

70%

72%

71%

Loan loss rate (bps)

245

211

132

145

105

127

(49)

27

Analysis of total income

£m

£m

£m

£m

£m

£m

£m

£m

International Cards and Consumer Bank

860

824

691

538

552

490

517

533

Private Bank

285

270

245

214

200

188

214

179

Payments

141

150

147

134

126

130

109

93

Total income

1,286

1,244

1,083

886

878

808

840

805

 

Head Office

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

Income statement information

£m

£m

£m

£m

£m

£m

£m

£m

Net interest income

(324)

10

-

66

(38)

(112)

(64)

(178)

Net fee, commission and other income

293

(40)

(132)

(43)

(11)

2

37

103

Total income

(31)

(30)

(132)

23

(49)

(110)

(27)

(75)

Operating costs

(97)

(94)

(60)

(85)

(152)

(95)

(341)

(71)

UK bank levy

(17)

-

-

-

-

-

-

-

Litigation and conduct

1

(54)

1

(1)

(3)

(19)

16

(9)

Total operating expenses

(113)

(148)

(59)

(86)

(155)

(114)

(325)

(80)

Other net income/(expenses)

4

(10)

2

(18)

11

78

8

123

Loss before impairment

(140)

(188)

(189)

(81)

(193)

(146)

(344)

(32)

Credit impairment (charges)/releases

(13)

(5)

9

8

(5)

(1)

6

-

Loss before tax

(153)

(193)

(180)

(73)

(198)

(147)

(338)

(32)

Attributable (loss)/profit

(63)

(173)

(170)

(292)

(159)

(134)

120

(25)

Balance sheet information

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Total assets

19.2

18.7

19.8

19.9

19.0

18.5

18.3

17.7

Risk weighted assets1

8.6

8.2

8.6

11.0

11.0

11.8

12.0

10.7

Period end allocated tangible equity1

(0.2)

(3.5)

1.1

3.6

5.5

6.3

5.9

3.3

Performance measures1

Average allocated tangible equity (£bn)

(2.4)

(0.4)

1.7

3.6

5.1

6.5

4.2

4.3

 

1

The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

 

Performance Management

 

Margins and balances

Year ended 31.12.22

Year ended 31.12.21

Net interest income

Average customer assets

Net interest margin

Net interest income

Average customer assets

Net interest margin

£m

£m

%

£m

£m

%

Barclays UK

5,893

205,972

2.86

5,202

206,628

2.52

Corporate and Investment Bank1

1,796

56,008

3.21

1,238

47,725

2.59

Consumer, Cards and Payments

2,979

39,193

7.60

1,911

30,805

6.21

Barclays International1

4,775

95,201

5.02

3,149

78,530

4.01

Total Barclays UK and Barclays International

10,668

301,173

3.54

8,351

285,158

2.93

Other2

(96)

(278)

Total Barclays Group

10,572

8,073

 

1

CIB and Barclays International margins include the lending related investment bank business.

2

Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins.

 

The Group NIM increased 61bps to 3.54%. Barclays UK NIM increased 34bps to 2.86%, reflecting the impact of higher UK interest rates. Barclays International NIM increased 101bps to 5.02%. CIB NIM increased 62bps to 3.21% and CC&P NIM increased 139bps to 7.60%, reflecting the impact of balance growth and higher interest rates.

 

The Group's combined product and equity structural hedge notional as at 31 December 2022 was £263bn (31 December 2021: £228bn), with an average duration of approximately 2.5 years (2021: average duration close to 3 years). Gross structural hedge contributions of £2,196m (2021: £1,415m) and net structural hedge contributions of £(1,544)m (2021: £1,187m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.

 

Quarterly analysis for Barclays UK and Barclays International

Net interest income

 

Average customer assets

Net interest margin

Three months ended 31.12.22

£m

£m

%

Barclays UK

1,600

204,941

3.10

Corporate and Investment Bank

556

59,146

3.73

Consumer, Cards and Payments

918

43,319

8.40

Barclays International1

1,474

102,465

5.71

Total Barclays UK and Barclays International

3,074

307,406

3.97

Three months ended 30.09.22

Barclays UK

1,561

205,881

3.01

Corporate and Investment Bank

529

58,891

3.56

Consumer, Cards and Payments

891

42,019

8.41

Barclays International1

1,420

100,910

5.58

Total Barclays UK and Barclays International

2,981

306,791

3.85

Three months ended 30.06.22

Barclays UK

1,393

205,834

2.71

Corporate and Investment Bank

397

55,181

2.88

Consumer, Cards and Payments

619

37,190

6.68

Barclays International1

1,016

92,371

4.41

Total Barclays UK and Barclays International

2,409

298,205

3.24

Three months ended 31.03.22

Barclays UK

1,339

207,607

2.62

Corporate and Investment Bank

316

50,798

2.52

Consumer, Cards and Payments

551

34,040

6.56

Barclays International1

867

84,838

4.15

Total Barclays UK and Barclays International

2,206

292,445

3.06

Three months ended 31.12.21

Barclays UK

1,313

209,064

2.49

Corporate and Investment Bank

326

48,310

2.67

Consumer, Cards and Payments

522

32,934

6.29

Barclays International1

848

81,244

4.14

Total Barclays UK and Barclays International

2,161

290,308

2.95

 

1

Barclays International margins include the lending related investment bank business.

 

Remuneration

 

Deferred bonuses are payable only once an employee meets certain conditions, including a specified period of future service. This creates a timing difference between the communication of the bonus pool and the charges that are recognised in the income statement which are reconciled in the table below to show the charge for performance costs. Refer to the Remuneration Report on pages 197 to 245 of the Barclays PLC Annual Report 2022 for further detail on remuneration. The table below includes the other elements of compensation and staff costs.

 

Year ended 31.12.22

Year ended 31.12.21

£m

£m

% Change

Incentive awards granted:

Current year bonus

1,241

1,278

3

Deferred bonus

549

667

18

Total incentive awards granted

1,790

1,945

8

Reconciliation of incentive awards granted to income statement charge:

Less: deferred bonuses granted but not charged in current year

(388)

(457)

15

Add: current year charges for deferred bonuses from previous years

399

280

(43)

Other differences between incentive awards granted and income statement charge

35

(23)

252

Income statement charge for performance costs

1,836

1,745

(5)

Other income statement charges:

Salaries

4,732

4,290

(10)

Social security costs

714

619

(15)

Post-retirement benefits1

563

539

(4)

Other compensation costs

504

431

(17)

Total compensation costs2

8,349

7,624

(10)

Other resourcing costs

Outsourcing

607

357

(70)

Redundancy and restructuring

(7)

296

102

Temporary staff costs

113

109

(4)

Other

190

125

(52)

Total other resourcing costs

903

887

(2)

Total staff costs

9,252

8,511

(9)

Group compensation costs as a % of total income

33.5

34.7

Group staff costs as a % of total income

37.1

38.8

 

One of the primary considerations for performance costs are Group and business level returns, alongside other financial and non-financial measures, including strategic delivery, risk and conduct, aligning colleague, shareholder and wider stakeholder interests.

 

1

Post-retirement benefits charge includes £313m (2021: £289m) in respect of defined contribution schemes and £250m (2021: £250m) in respect of defined benefit schemes.

2

£604m (2021: £484m) of Group compensation was capitalised as internally generated software and excluded from the Staff cost disclosed above.

 

Deferred bonuses have been awarded and are expected to be charged to the income statement in the years outlined in the table that follows:

 

Year in which income statement charge is expected to be taken for deferred bonuses awarded to date1

 

Actual

Expected1, 2

Year ended

Year ended

Year ended

2024 and

31.12.21

31.12.22

31.12.23

beyond

£m

£m

£m

£m

Deferred bonuses from 2019 and earlier bonus pools

141

52

50

-

Deferred bonuses from 2020 bonus pool

139

133

55

10

Deferred bonuses from 2021 bonus pool

210

214

165

102

Deferred bonuses from 2022 bonus pool

-

161

152

177

Income statement charge for deferred bonuses

490

560

422

289

 

1

The actual amount charged depends upon whether conditions have been met and may vary compared with the above expectation.

2

Does not include the impact of grants which will be made in 2023 and beyond.

 

Charging of deferred bonus profile1

 

Grant date

Expected payment date(s)2 and percentage of the deferred bonus paid

Year

Income statement charge % profile of 2022 onwards3,4

March 2023

2022

33%

2023

31%

March 2024 (33.3%)

2024

21%

March 2025 (33.3%)

2025

13%

March 2026 (33.3%)

2026

2%

 

1

Represents a typical vesting schedule for deferred awards. Certain awards may be subject to a 3, 4, 5 or 7 year deferral in line with regulatory requirements.

2

Share awards may be subject to an additional holding period.

3

The income statement charge is based on the period over which conditions are met.

4

Income statement charge profile % disclosed as a percentage of the award excluding lapse. The percentages have changed from last year due to introduction of 4 year awards.

 

Risk Management

 

Risk management and principal risks

 

The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking.

 

The framework identifies nine principal risks: credit risk, market risk, treasury and capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Further detail on the Group's principal risks and previously identified material existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual Report 2022, or online at home.barclays/annualreport.

 

The following section gives an overview of credit risk, market risk, and treasury and capital risk for the period.

 

Credit Risk

 

Loans and advances at amortised cost by stage

 

The table below presents a stage allocation and business segment analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio as at 31 December 2022. Also included are stage allocation of off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage as at 31 December 2022.

 

Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.

 

Gross exposure

Impairment allowance

Net exposure

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.22

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

160,424

24,837

2,711

187,972

232

718

485

1,435

186,537

Barclays International

33,735

4,399

1,793

39,927

392

1,200

949

2,541

37,386

Head Office

3,644

252

661

4,557

3

24

359

386

4,171

Total Barclays Group retail

197,803

29,488

5,165

232,456

627

1,942

1,793

4,362

228,094

Barclays UK

34,858

2,954

805

38,617

129

109

96

334

38,283

Barclays International

117,692

14,298

1,098

133,088

301

265

312

878

132,210

Head Office

192

-

18

210

-

-

18

18

192

Total Barclays Group wholesale1

152,742

17,252

1,921

171,915

430

374

426

1,230

170,685

Total loans and advances at amortised cost

350,545

46,740

7,086

404,371

1,057

2,316

2,219

5,592

398,779

Off-balance sheet loan commitments and financial guarantee contracts2

372,945

30,694

1,180

404,819

245

315

23

583

404,236

Total3

723,490

77,434

8,266

809,190

1,302

2,631

2,242

6,175

803,015

As at 31.12.22

Year ended 31.12.22

Coverage ratio

Loan impairment charge/(release) and loan loss rate

Stage 1

Stage 2

Stage 3

Total

Loan impairment charge/(release)

Loan loss rate

%

%

%

%

£m

bps

Barclays UK

0.1

2.9

17.9

0.8

169

9

Barclays International

1.2

27.3

52.9

6.4

763

191

Head Office

0.1

9.5

54.3

8.5

-

Total Barclays Group retail

0.3

6.6

34.7

1.9

932

40

Barclays UK

0.4

3.7

11.9

0.9

106

27

Barclays International

0.3

1.9

28.4

0.7

127

10

Head Office

-

-

100

8.6

-

Total Barclays Group wholesale1

0.3

2.2

22.2

0.7

233

14

Total loans and advances at amortised cost

0.3

5.0

31.3

1.4

1,165

29

Off-balance sheet loan commitments and financial guarantee contracts2

0.1

1.0

1.9

0.1

18

Other financial assets subject to impairment3

37

Total4

0.2

3.4

27.1

0.8

1,220

 

1

Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £6.6bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £3.8bn of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £14.9bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn and impairment allowance of £163m. This comprises £10m ECL on £178.4bn Stage 1 assets, £9m on £1.5bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £144m on £149m Stage 3 other assets.

4

The loan loss rate is 30bps after applying the total impairment charge of £1,220m.

 

Gross exposure

Impairment allowance

Net exposure

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.21

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

160,695

22,779

2,915

186,389

261

949

728

1,938

184,451

Barclays International

25,981

2,691

1,566

30,238

603

795

858

2,256

27,982

Head Office

3,735

429

705

4,869

2

36

347

385

4,484

Total Barclays Group retail

190,411

25,899

5,186

221,496

866

1,780

1,933

4,579

216,917

Barclays UK

35,571

1,917

969

38,457

153

43

111

307

38,150

Barclays International

92,341

13,275

1,059

106,675

187

192

458

837

105,838

Head Office

542

2

21

565

-

-

19

19

546

Total Barclays Group wholesale1

128,454

15,194

2,049

145,697

340

235

588

1,163

144,534

Total loans and advances at amortised cost

318,865

41,093

7,235

367,193

1,206

2,015

2,521

5,742

361,451

Off-balance sheet loan commitments and financial guarantee contracts2

312,142

34,815

1,298

348,255

217

302

23

542

347,713

Total3

631,007

75,908

8,533

715,448

1,423

2,317

2,544

6,284

709,164

As at 31.12.21

Year ended 31.12.21

Coverage ratio

Loan impairment charge/(release) and loan loss rate

Stage 1

Stage 2

Stage 3

Total

Loan impairment charge/(release)

Loan loss rate

%

%

%

%

£m

bps

Barclays UK

0.2

4.2

25.0

1.0

(227)

-

Barclays International

2.3

29.5

54.8

7.5

181

60

Head Office

0.1

8.4

49.2

7.9

-

-

Total Barclays Group retail

0.5

6.9

37.3

2.1

(46)

-

Barclays UK

0.4

2.2

11.5

0.8

122

32

Barclays International

0.2

1.4

43.2

0.8

(197)

-

Head Office

-

-

90.5

3.4

-

-

Total Barclays Group wholesale1

0.3

1.5

28.7

0.8

(75)

-

Total loans and advances at amortised cost

0.4

4.9

34.8

1.6

(121)

-

Off-balance sheet loan commitments and financial guarantee contracts2

0.1

0.9

1.8

0.2

(514)

Other financial assets subject to impairment3

(18)

Total

0.2

3.1

29.8

0.9

(653)

 

1

Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLS of £9.4bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £6.0bn of balances reported as wholesale loans on page 31 in the Loans and advances at amortised cost by product disclosure.

2

Excludes loan commitments and financial guarantees of £18.8bn carried at fair value.

3

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157m Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances and £107m on £110m Stage 3 other assets.

 

Loans and advances at amortised cost by product

 

The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.

 

Stage 2

As at 31.12.22

Stage 1

Not past due

>30 days past due

Total

Stage 3

Total

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

153,672

15,990

1,684

526

18,200

2,414

174,286

Credit cards, unsecured loans and other retail lending

44,175

7,126

397

576

8,099

2,122

54,396

Wholesale loans

152,698

20,194

150

97

20,441

2,550

175,689

Total

350,545

43,310

2,231

1,199

46,740

7,086

404,371

Impairment allowance

Home loans

29

53

11

9

73

414

516

Credit cards, unsecured loans and other retail lending

582

1,483

129

220

1,832

1,278

3,692

Wholesale loans

446

403

6

2

411

527

1,384

Total

1,057

1,939

146

231

2,316

2,219

5,592

Net exposure

Home loans

153,643

15,937

1,673

517

18,127

2,000

173,770

Credit cards, unsecured loans and other retail lending

43,593

5,643

268

356

6,267

844

50,704

Wholesale loans

152,252

19,791

144

95

20,030

2,023

174,305

Total

349,488

41,371

2,085

968

44,424

4,867

398,779

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.3

0.7

1.7

0.4

17.1

0.3

Credit cards, unsecured loans and other retail lending

1.3

20.8

32.5

38.2

22.6

60.2

6.8

Wholesale loans

0.3

2.0

4.0

2.1

2.0

20.7

0.8

Total

0.3

4.5

6.5

19.3

5.0

31.3

1.4

As at 31.12.21

Gross exposure

£m

£m

£m

£m

£m

£m

£m

Home loans

148,058

17,133

1,660

707

19,500

2,122

169,680

Credit cards, unsecured loans and other retail lending

37,840

5,102

300

248

5,650

2,332

45,822

Wholesale loans

132,967

15,246

306

391

15,943

2,781

151,691

Total

318,865

37,481

2,266

1,346

41,093

7,235

367,193

Impairment allowance

Home loans

19

46

6

7

59

397

475

Credit cards, unsecured loans and other retail lending

824

1,493

85

123

1,701

1,504

4,029

Wholesale loans

363

248

4

3

255

620

1,238

Total

1,206

1,787

95

133

2,015

2,521

5,742

Net exposure

Home loans

148,039

17,087

1,654

700

19,441

1,725

169,205

Credit cards, unsecured loans and other retail lending

37,016

3,609

215

125

3,949

828

41,793

Wholesale loans

132,604

14,998

302

388

15,688

2,161

150,453

Total

317,659

35,694

2,171

1,213

39,078

4,714

361,451

Coverage ratio

%

%

%

%

%

%

%

Home loans

-

0.3

0.4

1.0

0.3

18.7

0.3

Credit cards, unsecured loans and other retail lending

2.2

29.3

28.3

49.6

30.1

64.5

8.8

Wholesale loans

0.3

1.6

1.3

0.8

1.6

22.3

0.8

Total

0.4

4.8

4.2

9.9

4.9

34.8

1.6

 

Loans and advances at amortised cost by selected sectors

 

The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised cost with stage allocation for selected industry sectors within the wholesale loans portfolio. As the nature of macroeconomic uncertainty has evolved from the COVID-19 pandemic towards high inflation, supply chain constraints and consumer demand headwinds, so has the selected population under management focus. The credit risk industry concentration disclosure in the analysis of the concentration of credit risk section represents all the industry categories and the below only covers a subset of that table.

 

The gross loans and advances to selected sectors has decreased during the year. The increased provision is informed by the current macroeconomic outlook and underlying portfolio performance. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against credit losses. An additional £115m (December 2021: £123m) impairment allowance has been applied to the undrawn exposures not included in the table below.

 

Gross exposure

Impairment allowance

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.22

£m

£m

£m

£m

£m

£m

£m

£m

Autos

881

194

31

1,106

6

5

6

17

Consumer manufacture

3,845

1,729

199

5,773

45

41

46

132

Discretionary retail and wholesale

5,143

1,711

249

7,103

41

37

51

129

Hospitality and leisure

3,902

1,316

429

5,647

40

31

70

141

Passenger travel

744

267

51

1,062

9

7

13

29

Real estate

13,042

3,049

499

16,590

91

66

123

280

Steel and aluminium manufacturers

486

85

18

589

7

1

8

16

Total

28,043

8,351

1,476

37,870

239

188

317

744

Total of wholesale exposures (%)

18%

41%

58%

22%

54%

46%

60%

54%

Gross exposure

Impairment allowance

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

As at 31.12.21

£m

£m

£m

£m

£m

£m

£m

£m

Autos

656

295

2

953

3

3

-

6

Consumer manufacture

3,904

1,304

211

5,419

18

22

43

83

Discretionary retail and wholesale

5,413

1,197

230

6,840

47

20

54

121

Hospitality and leisure

4,348

1,613

384

6,345

28

33

44

105

Passenger travel

856

285

143

1,284

30

8

40

78

Real estate

13,620

3,314

518

17,452

65

53

93

211

Steel and aluminium manufacturers

415

75

6

496

2

3

1

6

Total

29,212

8,083

1,494

38,789

193

142

275

610

Total of wholesale exposures (%)

22%

51%

54%

26%

53%

56%

44%

49%

 

Exposure to UK Commercial Real Estate (CRE) of £9.7bn (2021: £10bn1) remained stable and was predominantly in Stage 1 at 81% (2021: 78%). The loan portfolio was well collateralised, hence a low coverage of 1.1% (ECL: £0.1bn). Exposure at Stage 3 was 2% (2021: 3%) with a coverage ratio of 12% (2021: 18%).

 

However, UK CRE has been included within selected sector scoping as the broader real estate sector remains under pressure due to pricing and affordability concerns, as well as construction input costs and supply chain issues adding to the uncertainty, in particular across non-investment grade exposures.

 

The coverage ratio for selected sectors has increased from 1.6% as at 31 December 2021 to 2.0% as at 31 December 2022. Non-default coverage ratio has increased from 0.9% as at 31 December 2021 to 1.2% as at 31 December 2022.

 

1

From 2022, Barclays has enhanced the process of identifying UK CRE exposures.

 

Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees

 

The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays PLC Annual Report 2022. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 12-month period.

 

Loans and advances at amortised cost

 

Stage 1

Stage 2

Stage 3

Total

Gross exposure

ECL

Gross exposure

ECL

Gross exposure

ECL

Gross exposure

ECL

Home loans

£m

£m

£m

£m

£m

£m

£m

£m

As at 1 January 2022

148,058

19

19,500

59

2,122

397

169,680

475

Transfers from Stage 1 to Stage 2

(8,747)

(1)

8,747

1

-

-

-

-

Transfers from Stage 2 to Stage 1

7,489

24

(7,489)

(24)

-

-

-

-

Transfers to Stage 3

(400)

-

(725)

(6)

1,125

6

-

-

Transfers from Stage 3

32

1

229

4

(261)

(5)

-

-

Business activity in the period1

30,028

10

1,142

7

6

-

31,176

17

Refinements to models used for calculation

-

-

-

-

-

-

-

-

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes

(8,846)

(22)

(1,081)

36

(125)

52

(10,052)

66

Final repayments2

(13,942)

(2)

(2,123)

(4)

(426)

(9)

(16,491)

(15)

Disposals

-

-

-

-

-

-

-

-

Write-offs3

-

-

-

-

(27)

(27)

(27)

(27)

As at 31 December 20224

153,672

29

18,200

73

2,414

414

174,286

516

Credit cards, unsecured loans and other retail lending

As at 1 January 2022

37,840

824

5,650

1,701

2,332

1,504

45,822

4,029

Transfers from Stage 1 to Stage 2

(3,474)

(80)

3,474

80

-

-

-

-

Transfers from Stage 2 to Stage 1

1,941

489

(1,941)

(489)

-

-

-

-

Transfers to Stage 3

(649)

(20)

(707)

(307)

1,356

327

-

-

Transfers from Stage 3

87

33

25

13

(112)

(46)

-

-

Business activity in the period1

11,339

177

769

186

157

126

12,265

489

Refinements to models used for calculation5

-

86

-

(45)

-

96

-

137

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes

1,246

(887)

1,199

736

179

787

2,624

636

Final repayments2

(3,996)

(36)

(341)

(32)

(228)

(60)

(4,565)

(128)

Disposals6

(159)

(4)

(29)

(11)

(275)

(169)

(463)

(184)

Write-offs3

-

-

-

-

(1,287)

(1,287)

(1,287)

(1,287)

As at 31 December 20224

44,175

582

8,099

1,832

2,122

1,278

54,396

3,692

 

1

Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'. Business activity reported within Credit cards, unsecured loans and other retail lending portfolio includes Gap portfolio acquisition in US cards of £2.7bn.

2

Final repayments include repayment from the facility closed during the year whereas partial repayments from existing facility are reported under 'Net drawdowns, repayments, net remeasurement and movements due to exposure and risk parameter changes'.

3

In 2022, gross write-offs amounted to £1,620m (2021: £1,836m). In Q422, £329m of balances with de minimis recovery expectations were written-off in line with policy in UK Cards and Unsecured Loans. Post write-off recoveries amounted to £64m (2021: £66m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,556m (2021: £1,770m).

4

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn (December 21: £155.2bn) and an impairment allowance of £163m (December 21: £114m). This comprises £10m ECL (December 21: £6m) on £178.4bn Stage 1 assets (December 21: £154.9bn), £9m (December 21: £1m) on £1.5bn Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157m) and £144m (December 21: £107m) on £149m Stage 3 other assets (December 21: £110m).

5

Refinements to models used for calculation reported within Credit cards, unsecured loans and other retail lending portfolio include a £0.3bn movement in US Cards and £(0.2)bn movement in UK Cards. These reflect model enhancements made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses.

6

The £0.5bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £0.2bn sale of NFL portfolio within US Cards and £0.3bn of debt sales undertaken during the year.

 

Loans and advances at amortised cost

Stage 1

Stage 2

Stage 3

Total

Gross exposure

ECL

Gross exposure

ECL

Gross exposure

ECL

Gross exposure

ECL

Wholesale loans

£m

£m

£m

£m

£m

£m

£m

£m

As at 1 January 2022

132,967

363

15,943

255

2,781

620

151,691

1,238

Transfers from Stage 1 to Stage 2

(9,488)

(67)

9,488

67

-

-

-

-

Transfers from Stage 2 to Stage 1

5,258

55

(5,258)

(55)

-

-

-

-

Transfers to Stage 3

(1,480)

(6)

(684)

(11)

2,164

17

-

-

Transfers from Stage 3

204

21

339

28

(543)

(49)

-

-

Business activity in the period1

40,490

83

4,104

86

239

30

44,833

199

Refinements to models used for calculation2

-

(64)

-

(66)

-

(374)

-

(504)

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes3

12,799

103

352

154

(1,504)

693

11,647

950

Final repayments4

(26,540)

(42)

(3,812)

(47)

(232)

(57)

(30,584)

(146)

Disposals5

(1,512)

-

(31)

-

(49)

(47)

(1,592)

(47)

Write-offs6

-

-

-

-

(306)

(306)

(306)

(306)

As at 31 December 20227

152,698

446

20,441

411

2,550

527

175,689

1,384

Reconciliation of ECL movement to impairment charge/(release) for the period

Stage 1

Stage 2

Stage 3

Total

£m

£m

£m

£m

Home loans

10

14

44

68

Credit cards, unsecured loans and other retail lending

(238)

142

1,230

1,134

Wholesale loans

83

156

260

499

ECL movement excluding assets derecognised due to disposals and write-offs

(145)

312

1,534

1,701

ECL movement on loan commitments and other financial guarantees

28

13

-

41

ECL movement on other financial assets7

4

8

37

49

Recoveries and reimbursements8

(122)

(63)

(78)

(263)

Total exchange and other adjustments9

(308)

Total income statement charge for the period

1,220

 

1

Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes'.

2

Refinements to models used for calculation reported within Wholesale loans include a £(0.5)bn movement in Business Banking. This relates to an update in the underlying ECL model that now fully recognises the 100% government guarantee against Barclays Bounce Back Loans exposure.

3

'Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes' reported within Wholesale loans also include assets of £1.3bn de-recognised due to payment received on defaulted loans from government guarantees issued under government's Bounce Back Loans Scheme.

4

Final repayments include repayment from the facilities closed during the year whereas partial repayments from existing facility are reported under 'Net drawdowns, repayments, net remeasurement and movements due to exposure and risk parameter changes'.

5

The £1.6bn disposals reported within Wholesale loans includes sale of debt securities as part of Group Treasury Operations.

6

In 2022, gross write-offs amounted to £1,620m (2021: £1,836m). In Q422, £329m of balances with de minimis recovery expectations were written-off in line with policy in UK Cards and Unsecured Loans. Post write-off recoveries amounted to £64m (2021: £66m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £1,556m (2021: £1,770m).

7

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.1bn (December 21: £155.2bn) and impairment allowance of £163m (December 21: £114m). This comprises £10m ECL (December 21: £6m) on £178.4bn stage 1 assets (December 21: £154.9bn), £9m (December 21: £1m) on £1.5bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157m) and £144m (December 21: £107m) on £149m stage 3 other assets (December 21: £110m).

8

Recoveries and reimbursements includes £199m (2021 loss: £306m) for reimbursements expected to be received under the arrangement where Group has entered into financial guarantee contracts which provide credit protection over certain loan assets with third parties and cash recoveries of previously written off amounts of £64m (FY21: £66m).

9

Exchange and other adjustments includes foreign exchange and interest and fees in suspense.

 

Loan commitments and financial guarantees

Stage 1

Stage 2

Stage 3

Total

Gross

exposure

ECL

Gross

exposure

ECL

Gross

exposure

ECL

Gross

exposure

ECL

Home loans

£m

£m

£m

£m

£m

£m

£m

£m

As at 1 January 2022

10,833

-

532

-

3

-

11,368

-

Net transfers between stages

8

-

(17)

-

9

-

-

-

Business activity in the period

8,034

-

-

-

-

-

8,034

-

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes

(6,793)

-

(21)

-

(6)

-

(6,820)

-

Limit management and final repayments

(368)

-

(44)

-

-

-

(412)

-

As at 31 December 2022

11,714

-

450

-

6

-

12,170

-

Credit cards, unsecured loans and other retail lending

As at 1 January 2022

122,819

50

5,718

61

218

20

128,755

131

Net transfers between stages

(3,390)

47

3,050

(42)

340

(5)

-

-

Business activity in the period

38,204

25

451

27

14

2

38,669

54

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes

9,633

(54)

(1,949)

67

(151)

5

7,533

18

Limit management and final repayments

(8,212)

(7)

(503)

(23)

(89)

(2)

(8,804)

(32)

As at 31 December 2022

159,054

61

6,767

90

332

20

166,153

171

Wholesale loans

As at 1 January 2022

178,490

167

28,565

241

1,077

3

208,132

411

Net transfers between stages

5,826

60

(5,759)

(64)

(67)

4

-

-

Business activity in the period

43,683

28

4,233

54

15

-

47,931

82

Net drawdowns, repayments, net re-measurement and movement due to exposure and risk parameter changes

28,353

(42)

5,953

59

138

(2)

34,444

15

Limit management and final repayments

(54,175)

(29)

(9,515)

(65)

(321)

(2)

(64,011)

(96)

As at 31 December 2022

202,177

184

23,477

225

842

3

226,496

412

 

Management adjustments to models for impairment

 

Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable.

 

Management adjustments are captured through "Economic uncertainty" and "Other" adjustments presented by product below:

 

Management adjustments to models for impairment allowance presented by product1

Impairment allowance pre management adjustments2

Economic uncertainty adjustments

Other adjustments

Management adjustments

Total impairment allowance3

Proportion of Management adjustments to total impairment allowance

(a)

(b)

(a+b)

As at 31 December 2022

£m

£m

£m

£m

£m

%

Home loans

427

4

85

89

516

17.2

Credit cards, unsecured loans and other retail lending

3,543

118

202

320

3,863

8.3

Wholesale loans

1,680

195

(79)

116

1,796

6.5

Total

5,650

317

208

525

6,175

8.5

As at 31 December 2021

£m

£m

£m

£m

£m

%

Home loans

372

72

31

103

475

21.7

Credit cards, unsecured loans and other retail lending

2,798

1,217

145

1,362

4,160

32.7

Wholesale loans

1,628

403

(382)

21

1,649

1.3

Total

4,798

1,692

(206)

1,486

6,284

23.6

 

Economic uncertainty adjustments presented by stage

 

Stage 1

Stage 2

Stage 3

Total

As at 31 December 2022

£m

£m

£m

£m

Home loans

1

3

-

4

Credit cards, unsecured loans and other retail lending

24

93

1

118

Wholesale loans

181

14

-

195

Total

206

110

1

317

 

As at 31 December 2021

£m

£m

£m

£m

Home loans

5

35

32

72

Credit cards, unsecured loans and other retail lending

403

803

11

1,217

Wholesale loans

333

70

-

403

Total

741

908

43

1,692

 

1

Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance.

2

Includes £4.8bn (December 2021: £4.2bn) of modelled ECL, £0.4bn (December 2021: £0.5bn) of individually assessed impairments and £0.5bn (December 2021: £0.1bn) ECL from non-modelled exposures.

3

Total impairment allowance consists of ECL stock on drawn and undrawn exposure.

 

Economic uncertainty adjustments

 

Models have been developed with data from non-inflationary periods establishing a relationship between input variables and customer delinquency based on past behaviour. Additionally, models are trying to interpret significant rates of change in macroeconomic variables and applying these to stable probability of default (PD) levels. As such there is a risk that the modelled output fails to capture the appropriate response to changes in macroeconomic variables and rising costs with modelled impairment provisions impacted by uncertainty.

 

This uncertainty continues to be captured in two ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to economic instability; and secondly, model uncertainty: to capture the impact from model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level.

 

In 2022, previously established economic uncertainty adjustments have been partially released, informed by some normalisation of customer behaviour, refreshed scenarios and a rebuild of certain models to better capture the macroeconomic outlook.

 

The balance as at 31 December 2022 is £317m (December 2021: £1,692m) and includes:

Customer and client uncertainty provisions of £423m (December 2021: £1,508m) includes:

·

Credit cards, unsecured loans and other retail lending includes an adjustment of £118m (December 2021: £1,203m) which has been applied to customers and clients considered most vulnerable to affordability pressures. This adjustment is predominantly held in Stage 2 in line with customer risk profiles.

 

The reduction is informed by the release of COVID-19 related adjustments as credit performance stabilises at or below pre-pandemic levels which is reflected in the models, and a rebuild of certain models to better capture the macroeconomic outlook.

·

Wholesale loans: £301m (FY21: £305m) includes an adjustment of £205m for exposures considered most at risk from inflationary concerns, supply chain constraints and consumer demand headwinds. The adjustment involves applying Stage 2 coverage rates to Stage 1 exposures assessed as most vulnerable. Sectors in scope are presented in the selected sectors disclosure on page 32. The remaining adjustment includes £92m to reflect possible cross default risk on Barclays' lending in respect of clients who have taken bounce back loans.

Model uncertainty provisions of £(106)m (December 2021: £184m) includes:

·

Wholesale loans: £(106)m (December 2021: £98m) includes an adjustment to correct for the deterioration in wholesale PDs impacted by model over-sensitivity to certain macroeconomic variables. In 2021, this adjustment was held at £98m driven by an unintuitive model output from certain Q421 macroeconomic variables.

·

Management adjustments of £72m within home loans in 2021 primarily comprised of a now retired adjustment, reflecting the non-linearity of the UK mortgages portfolio in order to generate a more appropriate level of predicted results.

 

Other adjustments

 

Other adjustments are operational in nature and are expected to remain in place until they can be reflected in the underlying models. These adjustments result from data limitations and model performance related issues identified through model monitoring and other established governance processes.

 

Other adjustments of £208m (December 2021: £(206)m) includes:

·

Home loans: £85m (December 2021: £31m) primarily includes adjustments for model performance informed by model monitoring and an adjustment for the adoption of the new definition of default under the Capital Requirements Regulation.

·

Credit cards, unsecured loans and other retail lending: £202m (December 2021: £145m) primarily includes an adjustment for adoption of the new definition of default under the Capital Requirements Regulation and an adjustment to the qualitative measures used in identification of high-risk account management (HRAM) accounts for US cards, partially offset by a recalibration of Loss Given Default (LGD) to reflect revised recovery expectations.

 

The £145m adjustments held in December 2021 primarily included adjustments for model performance informed by model monitoring, partially offset by an adjustment for reclassification of loans and advances from Stage 2 to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of origination probability of default characteristics require management adjustment. These adjustments are no longer required due to model enhancements made during the year.

·

Wholesale loans: £(79)m (December 2021: £(382)m): includes adjustments for model performance informed by model monitoring.

 

Management adjustments of £(382)m within wholesale loans in 2021 consisted of an adjustment of £(380)m applied on bounce back loans to reverse out the modelled charge which did not consider the government guarantee. This adjustment is no longer needed due to model enhancements made during the year.

 

Measurement uncertainty

 

Scenarios used to calculate the Group's ECL charge were refreshed in Q422 with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh. In the Baseline scenario, further deterioration in major economies, as inflation pressures continue to squeeze household income, along with significant monetary policy tightening contribute to lower growth prospects. UK GDP is expected to continue falling into 2023 and the US economy dips into mild recession in 2023. Slight increases in the UK and US unemployment rates are expected, peaking at 4.9% in Q423 and 4.7% in Q124 respectively. Central banks continue raising interest rates, peaking during 2023, and consumer price inflation eases over 2023.

 

In the Downside 2 scenario, inflation continues to accelerate amid increasing gas and oil prices and persistent supply-chain pressures as a result of the Russia-Ukraine conflict. Central banks are forced to raise interest rates sharply with the UK bank rate reaching 8% and the US federal funds rate peaking at 7%. Unemployment peaks at 8.5% in the UK and 8.6% in the US. Given already stretched valuations, the sharp increase in borrowing costs sees house prices decrease significantly. In the Upside 2 scenario, lower energy prices add downward pressure on prices globally, while recovering labour force participation limits wage growth. As a result of easing inflation, central banks lower interest rates to support the economic recovery.

 

The methodology for estimating scenario probability weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The median is centred around the Baseline with scenarios further from the Baseline attracting a lower weighting before the five weights are normalised to total 100%. The increase in the Downside weightings and the decrease in the Upside weightings reflected the deteriorating economic outlook which moved the Baseline UK/US GDP paths closer to the Downside scenarios. For further details see page 41.

 

The economic uncertainty adjustments of £0.3bn (2021: £1.7bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £0.4bn (2021: £1.5bn) which has been applied to customers and clients considered most vulnerable to affordability pressures, and a model uncertainty adjustment of £(0.1)bn (2021: £0.2bn). For further details see page 36.

 

The tables below show the key macroeconomic variables used in the five scenarios (5 year annual paths), the probability weights applied to each scenario.

 

Baseline average macroeconomic variables used in the calculation of ECL

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(0.8)

0.9

1.8

1.9

UK unemployment2

3.7

4.5

4.4

4.1

4.2

UK HPI3

8.4

(4.7)

(1.7)

2.2

2.2

UK bank rate

1.8

4.4

4.1

3.8

3.4

US GDP1

1.8

0.5

1.2

1.5

1.5

US unemployment4

3.7

4.3

4.7

4.7

4.7

US HPI5

11.2

1.8

1.5

2.3

2.4

US federal funds rate

2.1

4.8

3.6

3.1

3.0

2021

2022

2023

2024

2025

As at 31.12.21

%

%

%

%

%

UK GDP1

6.2

4.9

2.3

1.9

1.7

UK unemployment2

4.8

4.7

4.5

4.3

4.2

UK HPI3

4.7

1.0

1.9

1.9

2.3

UK bank rate

0.1

0.8

1.0

1.0

0.8

US GDP1

5.5

3.9

2.6

2.4

2.4

US unemployment4

5.5

4.2

3.6

3.6

3.6

US HPI5

11.8

4.5

5.2

4.9

5.0

US federal funds rate

0.2

0.3

0.9

1.2

1.3

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Downside 2 average economic variables used in the calculation of ECL

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(3.4)

(3.8)

2.0

2.3

UK unemployment2

3.7

6.0

8.4

8.0

7.4

UK HPI3

8.4

(18.3)

(18.8)

(7.7)

8.2

UK bank rate

1.8

7.3

7.9

6.6

5.5

US GDP1

1.8

(2.7)

(3.4)

2.0

2.6

US unemployment4

3.7

6.0

8.5

8.1

7.1

US HPI5

11.2

(3.1)

(4.0)

(1.9)

4.8

US federal funds rate

2.1

6.6

6.9

5.8

4.6

2021

2022

2023

2024

2025

As at 31.12.21

%

%

%

%

%

UK GDP1

6.2

0.2

(4.0)

2.8

4.3

UK unemployment2

4.8

7.2

9.0

7.6

6.3

UK HPI3

4.7

(14.3)

(21.8)

11.9

15.2

UK bank rate

0.1

2.2

3.9

3.1

2.2

US GDP1

5.5

(0.8)

(3.5)

2.5

3.2

US unemployment4

5.5

6.4

9.1

8.1

6.4

US HPI5

11.8

(6.6)

(9.0)

5.9

6.7

US federal funds rate

0.2

2.1

3.4

2.6

2.0

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Downside 1 average economic variables used in the calculation of ECL

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

(2.1)

(1.5)

1.9

2.1

UK unemployment2

3.7

5.2

6.4

6.0

5.8

UK HPI3

8.4

(11.7)

(10.6)

(2.8)

5.2

UK bank rate

1.8

5.9

6.1

5.3

4.6

US GDP1

1.8

(1.1)

(1.1)

1.7

2.1

US unemployment4

3.7

5.1

6.6

6.4

5.9

US HPI5

11.2

(0.7)

(1.3)

0.2

3.6

US federal funds rate

2.1

5.8

5.4

4.4

3.9

2021

2022

2023

2024

2025

As at 31.12.21

%

%

%

%

%

UK GDP1

6.2

2.8

(0.7)

2.3

2.9

UK unemployment2

4.8

6.2

6.8

6.0

5.3

UK HPI3

4.7

(6.8)

(10.5)

6.9

8.6

UK bank rate

0.1

1.6

2.7

2.3

1.6

US GDP1

5.5

1.6

(0.4)

2.4

2.7

US unemployment4

5.5

5.4

6.6

6.1

5.2

US HPI5

11.8

(1.2)

(2.1)

4.8

5.2

US federal funds rate

0.2

1.3

2.3

2.1

1.8

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Upside 2 average economic variables used in the calculation of ECL

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

2.8

3.7

2.9

2.4

UK unemployment2

3.7

3.5

3.4

3.4

3.4

UK HPI3

8.4

8.7

7.5

4.4

4.2

UK bank rate

1.8

3.1

2.6

2.5

2.5

US GDP1

1.8

3.3

3.5

2.8

2.8

US unemployment4

3.7

3.3

3.3

3.3

3.3

US HPI5

11.2

5.8

5.1

4.5

4.5

US federal funds rate

2.1

3.6

2.9

2.8

2.8

2021

2022

2023

2024

2025

As at 31.12.21

%

%

%

%

%

UK GDP1

6.2

7.2

4.0

2.7

2.1

UK unemployment2

4.8

4.5

4.1

4.0

4.0

UK HPI3

4.7

8.5

9.0

5.2

4.2

UK bank rate

0.1

0.2

0.5

0.5

0.3

US GDP1

5.5

5.3

4.1

3.5

3.4

US unemployment4

5.5

3.9

3.4

3.3

3.3

US HPI5

11.8

10.6

8.5

7.2

6.6

US federal funds rate

0.2

0.3

0.4

0.7

1.0

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Upside 1 average economic variables used in the calculation of ECL

2022

2023

2024

2025

2026

As at 31.12.22

%

%

%

%

%

UK GDP1

3.3

1.0

2.3

2.4

2.1

UK unemployment2

3.7

4.0

3.9

3.8

3.8

UK HPI3

8.4

1.8

2.9

3.3

3.2

UK bank rate

1.8

3.5

3.3

3.0

2.8

US GDP1

1.8

1.9

2.3

2.2

2.2

US unemployment4

3.7

3.8

4.0

4.0

4.0

US HPI5

11.2

3.8

3.3

3.4

3.4

US federal funds rate

2.1

3.9

3.4

3.0

3.0

2021

2022

2023

2024

2025

As at 31.12.21

%

%

%

%

%

UK GDP1

6.2

6.0

3.1

2.3

1.9

UK unemployment2

4.8

4.6

4.3

4.2

4.1

UK HPI3

4.7

5.0

5.0

3.9

3.3

UK bank rate

0.1

0.6

0.8

0.8

0.5

US GDP1

5.5

4.6

3.4

2.9

2.9

US unemployment4

5.5

4.0

3.5

3.5

3.5

US HPI5

11.8

8.3

7.0

6.0

5.7

US federal funds rate

0.2

0.3

0.6

1.0

1.1

 

1

Average Real GDP seasonally adjusted change in year.

2

Average UK unemployment rate 16-year+.

3

Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end.

4

Average US civilian unemployment rate 16-year+.

5

Change in year end US HPI = FHFA House Price Index, relative to prior year end.

 

Scenario probability weighting1

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

%

%

%

%

%

As at 31.12.22

Scenario probability weighting

10.9

23.1

39.4

17.6

9.0

As at 31.12.21

Scenario probability weighting

20.9

27.2

30.1

14.8

7.0

 

1

For further details on changes to scenario weights please see page 38.

 

Specific bases show the most extreme position of each variable in the context of the downside/upside scenarios, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest cumulative position relative to the start point, in the 20 quarter period.

 

Macroeconomic variables (specific bases)1

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

As at 31.12.22

%

%

%

%

%

UK GDP2

13.9

9.4

1.4

(3.2)

(6.8)

UK unemployment3

3.4

3.6

4.2

6.6

8.5

UK HPI4

37.8

21.0

1.2

(17.9)

(35.0)

UK bank rate

0.5

0.5

3.5

6.3

8.0

US GDP2

14.1

9.6

1.3

(2.5)

(6.3)

US unemployment3

3.3

3.6

4.4

6.7

8.6

US HPI4

35.0

27.5

3.8

3.7

0.2

US federal funds rate

0.1

0.1

3.3

6.0

7.0

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

As at 31.12.21

%

%

%

%

%

UK GDP2

21.4

18.3

3.4

(1.6)

(1.6)

UK unemployment3

4.0

4.1

4.5

7.0

9.2

UK HPI4

35.7

23.8

2.4

(12.7)

(29.9)

UK bank rate

0.1

0.1

0.7

2.8

4.0

US GDP2

22.8

19.6

3.4

1.5

(1.3)

US unemployment3

3.3

3.5

4.1

6.8

9.5

US HPI4

53.3

45.2

6.2

2.2

(5.0)

US federal funds rate

0.1

0.1

0.8

2.3

3.5

 

1

UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q122 (2021: Q121).

2

Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.

3

Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.

4

Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios.

 

Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively.

 

Macroeconomic variables (5-year averages)1

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

As at 31.12.22

%

%

%

%

%

UK GDP2

3.0

2.2

1.4

0.7

-

UK unemployment3

3.5

3.8

4.2

5.4

6.7

UK HPI4

6.6

3.9

1.2

(2.6)

(6.4)

UK bank rate

2.5

2.9

3.5

4.7

5.8

US GDP2

2.9

2.1

1.3

0.7

-

US unemployment3

3.4

3.9

4.4

5.5

6.7

US HPI4

6.2

5.0

3.8

2.5

1.2

US federal funds rate

2.8

3.1

3.3

4.3

5.2

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

As at 31.12.21

%

%

%

%

%

UK GDP2

4.4

3.9

3.4

2.7

1.8

UK unemployment3

4.3

4.4

4.5

5.8

7.0

UK HPI4

6.3

4.4

2.4

0.3

(2.0)

UK bank rate

0.3

0.5

0.7

1.7

2.3

US GDP2

4.4

3.9

3.4

2.4

1.3

US unemployment3

3.9

4.0

4.1

5.7

7.1

US HPI4

8.9

7.7

6.2

3.6

1.4

US federal funds rate

0.5

0.6

0.8

1.5

2.1

 

1

UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index.

2

5-year yearly average CAGR, starting 2021 (2021: 2020).

3

5-year average. Period based on 20 quarters from Q122 (2021: Q121).

4

5-year quarter end CAGR, starting Q421 (2021: Q420).

 

ECL under 100% weighted scenarios for modelled portfolios

 

The table below shows the modelled ECL assuming each of the five modelled scenarios are 100% weighted with the dispersion of results around the Baseline, highlighting the impact on exposure and ECL across the scenarios. Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures.

 

Scenarios

As at 31 December 2022

Weighted1

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

Stage 1 Model Exposure (£m)

Home loans

144,701

147,754

146,873

145,322

142,599

138,619

Credit cards, unsecured loans and other retail lending2, 3

81,329

81,772

81,457

81,171

80,921

80,529

Wholesale loans

186,838

194,970

192,218

188,746

181,247

167,848

Stage 1 Model ECL (£m)

Home loans

7

3

3

4

9

30

Credit cards, unsecured loans and other retail lending

592

562

579

594

604

610

Wholesale loans

325

245

274

308

382

431

Stage 1 Coverage (%)

Home loans

-

-

-

-

-

-

Credit cards, unsecured loans and other retail lending

0.7

0.7

0.7

0.7

0.7

0.8

Wholesale loans

0.2

0.1

0.1

0.2

0.2

0.3

Stage 2 Model Exposure (£m)

Home loans

18,723

15,670

16,551

18,102

20,825

24,805

Credit cards, unsecured loans and other retail lending2, 3

9,414

8,131

8,817

9,535

10,377

11,456

Wholesale loans

25,634

17,503

20,255

23,726

31,226

44,624

Stage 2 Model ECL (£m)

Home loans

33

15

18

23

45

151

Credit cards, unsecured loans and other retail lending

1,786

1,487

1,629

1,785

2,004

2,274

Wholesale loans

603

392

463

562

809

1,288

Stage 2 Coverage (%)

Home loans

0.2

0.1

0.1

0.1

0.2

0.6

Credit cards, unsecured loans and other retail lending

19.0

18.3

18.5

18.7

19.3

19.8

Wholesale loans

2.4

2.2

2.3

2.4

2.6

2.9

Stage 3 Model Exposure (£m)4

Home loans

1,553

1,553

1,553

1,553

1,553

1,553

Credit cards, unsecured loans and other retail lending

1,606

1,606

1,606

1,606

1,606

1,606

Wholesale loans

2,855

2,855

2,855

2,855

2,855

2,855

Stage 3 Model ECL (£m)

Home loans

332

311

317

323

347

405

Credit cards, unsecured loans and other retail lending

1,033

1,011

1,023

1,034

1,048

1,059

Wholesale loans5

49

45

47

49

57

64

Stage 3 Coverage (%)

Home loans

21.4

20.0

20.4

20.8

22.3

26.1

Credit cards, unsecured loans and other retail lending

64.3

63.0

63.7

64.4

65.3

65.9

Wholesale loans5

1.7

1.6

1.6

1.7

2.0

2.2

Total Model ECL (£m)

Home loans

372

329

338

350

401

586

Credit cards, unsecured loans and other retail lending

3,411

3,060

3,231

3,413

3,656

3,943

Wholesale loans5

977

682

784

919

1,248

1,783

Total Model ECL

4,760

4,071

4,353

4,682

5,305

6,312

 

Reconciliation to total ECL

£m

Total weighted model ECL

4,760

ECL from individually assessed impairments5

434

ECL from non-modelled exposures and others

456

ECL from post model management adjustments

525

Of which: ECL from economic uncertainty adjustments

317

Total ECL

6,175

 

1

Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach as required for Barclays reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned to a different stage dependent on the scenario.

2

For Credit cards, unsecured loans and other retail lending, the model exposure movement between stages 1 and 2 across scenarios differs due to additional impacts from the undrawn exposure.

3

For Credit cards, unsecured loans and other retail lending, the dispersion of results around Baseline has narrowed following model enhancements made during the year.

4

Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at 31 December 2022 and not on macroeconomic scenario.

5

Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £434m is reported as an individually assessed impairment in the reconciliation table.

 

The use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 1.7%.

 

Home loans: Total weighted ECL of £372m represents a 6.3% increase over the Baseline ECL (£350m) with coverage ratios remaining steady across the Upside scenarios, Baseline and Downside 1 scenario. Under the Downside 2 scenario, total ECL increases to £586m driven by a significant fall in UK HPI to (18.3)% in 2023 reflecting the non-linearity of the UK portfolio.

 

Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,411m is aligned to the Baseline ECL (£3,413m). The impact of the deteriorated Baseline scenario relative to the severity of the downside scenarios is greater than the impact of the higher weights applied to the Downside scenarios when compared to 2021. This results in a convergence between Baseline and Weighted ECL in 2022. Total ECL increases to £3,943m under the Downside 2 scenario, driven by the significant increase in UK unemployment rate to 6.0% and US unemployment rate to 6.0% in 2023.

 

Wholesale loans: Total weighted ECL of £977m represents an 6.3% increase over the Baseline ECL (£919m). Total ECL increases to £1,783m under Downside 2 scenario, driven by a significant decrease in UK GDP to (3.4)% and US GDP to (2.7)% in 2023.

 

Scenarios

As at 31 December 2021

Weighted1

Upside 2

Upside 1

Baseline

Downside 1

Downside 2

Stage 1 Model Exposure (£m)

Home loans

137,279

139,117

138,424

137,563

135,544

133,042

Credit cards, unsecured loans and other retail lending2, 3

56,783

54,758

55,771

56,821

57,698

55,315

Wholesale loans

174,249

177,453

176,774

175,451

169,814

161,998

Stage 1 Model ECL (£m)

Home loans

4

2

2

3

6

14

Credit cards, unsecured loans and other retail lending

324

266

272

279

350

418

Wholesale loans

290

240

262

286

327

350

Stage 1 Coverage (%)

Home loans

-

-

-

-

-

-

Credit cards, unsecured loans and other retail lending

0.6

0.5

0.5

0.5

0.6

0.8

Wholesale loans

0.2

0.1

0.1

0.2

0.2

0.2

Stage 2 Model Exposure (£m)

Home loans

22,915

21,076

21,769

22,631

24,649

27,151

Credit cards, unsecured loans and other retail lending2, 3

7,500

6,447

6,757

7,084

10,689

18,452

Wholesale loans

32,256

29,052

29,732

31,054

36,692

44,507

Stage 2 Model ECL (£m)

Home loans

15

10

11

12

22

47

Credit cards, unsecured loans and other retail lending

1,114

925

988

1,058

1,497

3,295

Wholesale loans

572

431

467

528

851

1,510

Stage 2 Coverage (%)

Home loans

0.1

-

0.1

0.1

0.1

0.2

Credit cards, unsecured loans and other retail lending

14.9

14.3

14.6

14.9

14.0

17.9

Wholesale loans

1.8

1.5

1.6

1.7

2.3

3.4

Stage 3 Model Exposure (£m)4

Home loans

1,724

1,724

1,724

1,724

1,724

1,724

Credit cards, unsecured loans and other retail lending

1,922

1,922

1,922

1,922

1,922

1,922

Wholesale loans

1,811

1,811

1,811

1,811

1,811

1,811

Stage 3 Model ECL (£m)

Home loans

303

292

295

299

320

346

Credit cards, unsecured loans and other retail lending

1,255

1,236

1,245

1,255

1,277

1,297

Wholesale loans5

323

321

322

323

326

332

Stage 3 Coverage (%)

Home loans

17.6

16.9

17.1

17.3

18.6

20.1

Credit cards, unsecured loans and other retail lending

65.3

64.3

64.8

65.3

66.4

67.5

Wholesale loans5

17.8

17.7

17.8

17.8

18.0

18.3

Total Model ECL (£m)

Home loans

322

304

308

314

348

407

Credit cards, unsecured loans and other retail lending

2,693

2,427

2,505

2,592

3,124

5,010

Wholesale loans5

1,185

992

1,051

1,137

1,504

2,192

Total Model ECL

4,200

3,723

3,864

4,043

4,976

7,609

 

Reconciliation to total ECL

£m

Total model ECL

4,200

ECL from individually assessed impairments5

524

ECL from non-modelled exposures and others

74

ECL from post model management adjustments6

1,486

Of which: ECL from economic uncertainty adjustments

1,692

Total ECL

6,284

 

1

Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach, as required for Barclays reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given balances may be assigned to a different stage dependent on the scenario.

2

For Credit cards, unsecured loans and other retail lending, the model exposure movement between stages 1 and 2 across scenarios differs due to additional impacts from the undrawn exposure.

3

In 2021, Loans & Advances at amortised cost were used as model exposure for the International Consumer Bank within this disclosure. The process was revised in 2022 to incorporate Exposure at Default (EAD) with no impact to ECL. This has been represented in prior year comparatives.

4

Model exposures allocated to Stage 3 does not change in any of the scenarios as the transition criteria relies only on an observable evidence of default as at 31 December 2021 and not on macroeconomic scenario.

5

Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as an individually assessed impairment in the reconciliation table.

6

Post Model Adjustments include negative adjustments reflecting operational post model adjustments.

 

Analysis of specific portfolios and asset types

 

Secured home loans

 

The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2021: 93%) of the Group's total home loans balance.

 

Barclays UK

Home loans principal portfolios

As at 31.12.22

As at 31.12.21

Gross loans and advances (£m)

162,380

158,192

90 day arrears rate, excluding recovery book (%)

0.1

0.1

Annualised gross charge-off rates - 180 days past due (%)

0.5

0.5

Recovery book proportion of outstanding balances (%)

0.5

0.6

Recovery book impairment coverage ratio (%)

5.2

4.2

Average marked to market LTV

Balance weighted %

50.4

50.7

Valuation weighted %

37.3

37.5

New lending

Year ended 31.12.22

Year ended 31.12.21

New home loan bookings (£m)

30,307

33,945

New home loan proportion > 90% LTV (%)

2.8

1.9

Average LTV on new home loans: balance weighted (%)

68.1

69.5

Average LTV on new home loans: valuation weighted (%)

59.6

61.9

 

Home loans principal portfolios - distribution of balances by LTV1

 

Distribution of balances

Distribution of impairment allowance

Coverage ratio

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

Stage 1

Stage 2

Stage 3

Total

Barclays UK

%

%

%

%

%

%

%

%

%

%

%

%

As at 31.12.22

78.8

10.5

0.8

90.1

10.2

30.8

33.2

74.2

-

0.2

2.9

0.1

>75% and

8.8

0.5

-

9.3

3.9

9.7

5.2

18.8

-

1.4

30.8

0.1

>90% and

0.6

-

-

0.6

0.3

0.3

2.4

3.0

-

1.5

85.0

0.4

>100%

-

-

-

-

0.1

0.6

3.3

4.0

0.4

21.4

64.9

13.1

As at 31.12.21

77.2

11.3

0.7

89.2

8.3

17.7

31.9

57.9

-

0.1

2.4

-

>75% and

9.3

0.6

-

9.9

4.8

10.7

11.7

27.2

-

1.0

22.6

0.1

>90% and

0.9

-

-

0.9

0.9

1.0

2.9

4.8

0.1

1.9

87.5

0.3

>100%

-

-

-

-

0.2

1.0

8.9

10.1

0.4

6.4

100.0

14.1

 

1

Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 31 December 2022.

 

New lending in 2022 was £30.3bn, a reduction of 11% on 2021. This was mainly driven by economic conditions that resulted in general mortgage market suppression, including higher mortgage payments as rates continued to rise and increased cost of living factors in line with inflation.

 

Head Office: Italian home loans and advances at amortised cost reduced to £4.5bn (2021: £4.7bn) and continue to run-off since new bookings ceased in 2016. The portfolio is secured on residential property with an average balance weighted mark to market LTV of 58.8% (2021: 60.4%). 90 day arrears decreased to 1.2% (2021: 1.3%), gross charge-off rates increased to 0.6% (2021: 0.3%) due to a combination of affordability stress related to rising inflation and interest rates, and the particularly low rate observed in 2021 due to the COVID portfolio improvements.

 

Credit cards, unsecured loans and other retail lending

 

The principal portfolios listed below accounted for 85% (December 2021: 82%) of the Group's total credit cards, unsecured loans and other retail lending.

 

Principal portfolios

Gross exposure

30 day arrears rate, excluding recovery book

90 day arrears rate, excluding recovery book

Annualised gross write-off rate

Annualised net write-off rate

As at 31.12.22

£m

%

%

%

%

Barclays UK

UK cards

9,939

0.9

0.2

3.7

3.6

UK personal loans

4,023

1.4

0.6

4.1

3.8

Barclays Partner Finance

2,612

0.5

0.2

0.7

0.7

Barclays International

US cards

25,554

2.2

1.2

2.4

2.3

Germany consumer lending

4,269

1.7

0.7

0.7

0.6

As at 31.12.21

Barclays UK

UK cards

9,933

1.0

0.2

4.1

4.0

UK personal loans

4,011

1.5

0.7

3.5

3.2

Barclays Partner Finance

2,471

0.4

0.2

1.4

1.4

Barclays International

US cards

17,779

1.6

0.8

4.3

4.2

Germany consumer lending

3,559

1.5

0.7

0.9

0.8

 

UK cards: 30 day arrears rate reduced marginally to 0.9% (Q421: 1.0%) and 90 day arrears rate remained stable at 0.2% (Q421: 0.2%), whilst total exposure was stable at £9.9bn. Both the gross and net write off rates decreased by 0.4% due to reduced debt sales and monthly delinquency flows.

 

UK personal loans: 30 and 90 day arrears rates have reduced marginally to 1.4% (Q421: 1.5%) and 0.6% (Q421: 0.7%) respectively, whilst total exposure was stable at £4.0bn. Both the annualised gross and net write off rates increased by 0.6% due to increased regular debt sales.

 

Barclays Partner Finance: 30 day arrears rate increased slightly to 0.5% (Q421: 0.4%) and 90 day arrears rate remained stable at 0.2% (Q421: 0.2%), reflecting marginally higher entry rates with stable flows through the delinquency cycles. Total exposure grew by £0.1bn to £2.6bn (December 2021: £2.5bn) as a result of increased sales. Both the annualised gross and net write off rates decreased by 0.7% as a result of the reducing delinquent stock and subsequent flow into recoveries.

 

US cards: Balances increased due to the acquisition of the Gap portfolio in June 2022, movement in the USD/GBP exchange rate and core portfolio growth. 30 and 90 day arrears rates increased to 2.2% (Q421: 1.6%) and 1.2% (Q421: 0.8%) due to the partial normalisation of customer behaviour and the acquisition of the Gap portfolio, though rates remain below pre-pandemic levels. Write-off rates decreased reflecting portfolio growth and the impact of lower charge offs in 2021 due to the benefit of government support schemes.

 

Germany consumer lending: 30 day arrears rate increased to 1.7% (Q421: 1.5%) due to increased macroeconomic uncertainty in Europe, though the rate was consistent with pre-pandemic levels.

 

Market Risk

 

Analysis of management value at risk (VaR)

 

The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material businesses and trading desks.

 

Management VaR (95%) by asset class

 

Year ended 31.12.22

Year ended 31.12.21

Average

High

Low

Average

High

Low

£m

£m

£m

£m

£m

£m

Credit risk

25

71

8

14

30

7

Interest rate risk

13

23

4

7

15

4

Equity risk

10

29

4

9

29

4

Basis risk

12

24

4

6

10

3

Spread risk

7

11

3

4

6

3

Foreign exchange risk

8

25

2

4

16

1

Commodity risk

-

1

-

-

1

-

Inflation risk

6

17

3

3

5

2

Diversification effect1

(45)

n/a

n/a

(28)

n/a

n/a

Total management VaR

36

73

13

19

36

6

 

1

Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.

 

Average management VaR increased 89% to £36m (2021: £19m) driven by higher market volatility. The Russia-Ukraine conflict and elevated inflation increased volatility across all asset classes as central banks increased base rates, equity markets declined, and credit spreads widened during this period. The Global Markets business maintained a generally short and defensive risk profile (i.e. positioned to gain as the market sells off) for most of 2022. VaR increased in Q4 2022 from an increase in funded, fair-value leverage loan exposure in Investment Banking. Risk taking remained within agreed risk appetite limits at all times in 2022.

 

Treasury and Capital Risk

 

The Group has established a comprehensive set of policies, standards and controls for managing its liquidity risk; together these set out the requirements for Barclays' liquidity risk framework. The liquidity risk framework meets the PRA standards and enables Barclays to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group's Liquidity Risk Appetite. The liquidity risk framework is delivered via a combination of policy formation, review and challenge, governance, analysis, stress testing, limit setting and monitoring.

 

Liquidity risk stress testing

The internal liquidity stress test measures the potential contractual and contingent stress outflows under a range of scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-wide scenario

 

The LCR requirement takes into account the relative stability of different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank's liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.

 

As at 31 December 2022, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external regulatory requirements.

 

Liquidity coverage ratio

As at 31.12.22

As at 31.12.21

£bn

£bn

Eligible liquidity buffer

295

285

Net stress outflows

(178)

(169)

Surplus

117

116

Liquidity coverage ratio

165%

168%

 

Net Stable Funding Ratio

 

The external NSFR metric requires banks to maintain a stable funding profile taking into account both on and certain off balance sheet exposures over a medium to long term period. The ratio is defined as the Available Stable Funding (capital and certain liabilities which are treated as stable sources of funding) relative to the Required Stable Funding (assets on balance sheet and certain off balance sheet exposures). The NSFR (average of last four quarter ends) as at 31 December 2022 was 137%, which was a surplus above requirements of £155bn. 

 

Net Stable Funding Ratio1

As at 31.12.22

£bn

Total Available Stable Funding

576

Total Required Stable Funding

421

Surplus

155

Net Stable Funding Ratio

137%

 

Represents average of the last four spot quarter end positions.

 

As part of the liquidity risk appetite, Barclays establishes minimum LCR, NSFR and internal liquidity stress test limits. The Group plans to maintain its surplus to the internal and regulatory requirements at an efficient level. Risks to market funding conditions, the Group's liquidity position and funding profile are assessed continuously, and actions are taken to manage the size of the liquidity pool and the funding profile as appropriate.

 

Composition of the Group liquidity pool

LCR eligible1 High Quality Liquid Assets (HQLA)

Liquidity pool

Cash

Level 1

Level 2A

Level 2B

Total

2022

2021

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Cash and deposits with central banks2

248

-

-

-

248

263

245

Government bonds3

AAA to AA-

-

21

10

-

31

39

26

A+ to A-

-

1

2

-

3

3

2

BBB+ to BBB-

-

-

-

-

-

-

-

Total government bonds

-

22

12

-

34

42

28

Other

Government Guaranteed Issuers, PSEs and GSEs

-

5

1

-

6

6

6

International Organisations and MDBs

-

2

-

-

2

2

5

Covered bonds

-

2

2

-

4

5

6

Other

-

-

-

1

1

-

1

Total other

-

9

3

1

13

13

18

Total as at 31 December 2022

248

31

15

1

295

318

Total as at 31 December 2021

243

37

3

2

285

291

 

1

The LCR eligible HQLA is adjusted for operational restrictions upon consolidation under Article 8 of the Liquidity Coverage Ratio section of the PRA rulebook (CRR) such as trapped liquidity within Barclays subsidiaries. It also reflects differences in eligibility of assets between the LCR and Barclays' Liquidity Pool.

2

Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99% (December 2021: over 99%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.

3

Of which over 79% (December 2021: over 82%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.

 

The Group liquidity pool increased to £318bn as at December 2022 (December 2021: £291bn) driven by continued deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption and trapped liquidity within Barclays' subsidiaries. During 2022, the month-end liquidity pool ranged from £309bn to £359bn (2021: £290bn to £337bn), and the month-end average balance was £331bn (2021: £303bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets.

 

As at 31 December 2022, 60% (December 2021: 58%) of the liquidity pool was located in Barclays Bank PLC, 25% (December 2021: 30%) in Barclays Bank UK PLC and 9% (December 2021: 7%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements or operational restrictions, it is assumed to be unavailable to the rest of the Group in calculating the LCR.

 

The composition of the pool is subject to limits and controls set by the respective entity Boards and independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.

 

Deposit funding

 

As at 31.12..22

As at 31.12.21

Loans and advances at amortised cost

Deposits at amortised cost

Loan: deposit ratio1

Loan: deposit ratio1

Funding of loans and advances

£bn

£bn

%

%

Barclays UK

225

258

87

85

Barclays International

170

288

59

52

Head Office

4

-

Barclays Group

399

546

73

70

 

1

The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.

 

Funding structure and funding relationships

 

The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due. The Group's overall funding strategy is to develop a diversified funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection against unexpected fluctuations, while minimising the cost of funding.

 

Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets.

 

These funding relationships as at 31 December 2022 are summarised below:

 

Restated1

As at 31.12.22

As at 31.12.21

As at 31.12.22

As at 31.12.21

Assets

£bn

£bn

Liabilities and equity

£bn

£bn

Loans and advances at amortised cost2

385

358

Deposits at amortised cost

546

519

Group liquidity pool

318

291

73

67

>1 Year wholesale funding

111

101

Reverse repurchase agreements, trading portfolio assets, cash collateral and settlement balances

412

388

Repurchase agreements, trading portfolio liabilities, cash collateral and settlement balances

370

330

Derivative financial instruments

302

263

Derivative financial instruments

290

257

Other assets3

97

84

Other liabilities

55

40

Equity

69

70

Total assets

1,514

1,384

Total liabilities and equity

1,514

1,384

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information. The contractual maturity profile of Senior unsecured (privately placed) has been restated to reflect the impact of the Over-issuance of Securities.

2

Adjusted for liquidity pool debt securities reported at amortised cost of £14bn (December 2021: £3bn).

3

Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.

 

Composition of wholesale funding

 

Wholesale funding outstanding (excluding repurchase agreements) was £184.0bn (December 2021: £167.5bn). In 2022, the Group issued £15.3bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies.

 

Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK PLC continued to issue in the shorter-term markets and maintains active secured funding programmes.

 

Wholesale funding of £72.5bn (December 2021: £66.7bn1) matures in less than one year, representing 39% (December 2021: 40%1) of total wholesale funding outstanding. This includes £15.0bn (December 2021: £24.9bn1) related to term funding2.

 

Maturity profile of wholesale funding2,3

 

1-3

3-6

6-12

1-2

2-3

3-4

4-5

>5

month

months

months

months

year

years

years

years

years

years

Total

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Barclays PLC (the Parent company)

Senior unsecured (public benchmark)

-

-

0.2

1.7

1.9

5.8

5.6

8.3

4.5

18.0

44.1

Senior unsecured (privately placed)

-

-

-

0.2

0.2

0.1

-

-

-

1.0

1.3

Subordinated liabilities

-

-

-

-

-

1.0

-

1.6

-

7.0

9.6

Barclays Bank PLC (including subsidiaries)

Certificates of deposit and commercial paper

0.3

17.7

12.8

11.0

41.8

1.5

0.6

0.1

-

-

44.0

Asset backed commercial paper

3.6

6.6

0.8

-

11.0

-

-

-

-

-

11.0

Senior unsecured (public benchmark)

-

-

-

-

-

1.0

-

-

-

-

1.0

Senior unsecured (privately placed)4

1.2

2.1

2.1

5.1

10.5

11.0

9.9

3.7

4.2

19.1

58.4

Asset backed securities

-

0.1

-

0.2

0.3

1.8

0.7

0.5

0.5

1.2

5.0

Subordinated liabilities

-

-

-

0.3

0.3

0.2

0.1

0.3

-

0.7

1.6

Barclays Bank UK PLC (including subsidiaries)

Certificates of deposit and commercial paper

4.7

-

-

-

4.7

-

-

-

-

-

4.7

Senior unsecured (public benchmark)

-

-

-

-

-

-

-

-

-

0.1

0.1

Covered Bonds

1.3

-

0.5

-

1.8

-

-

-

0.5

0.9

3.2

Total as at 31 December 2022

11.1

26.5

16.4

18.5

72.5

22.4

16.9

14.5

9.7

48.0

184.0

Of which secured

4.9

6.7

1.3

0.2

13.1

1.8

0.7

0.5

1.0

2.1

19.2

Of which unsecured

6.2

19.8

15.1

18.3

59.4

20.6

16.2

14.0

8.7

45.9

164.8

Total as at 31 December 20211

14.1

21.7

15.5

15.4

66.7

15.4

15.1

9.9

11.4

49.0

167.5

Of which secured

2.4

6.4

0.6

0.5

9.9

1.9

2.0

0.1

0.3

2.4

16.6

Of which unsecured

11.7

15.3

14.9

14.9

56.8

13.5

13.1

9.8

11.1

46.6

150.9

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information. The contractual maturity profile of financial liabilities designated at fair value has been restated to reflect the impact of the Over-issuance of Securities. Securities issued by BBPLC in excess of the maximum aggregate offering price registered under Barclays Bank PLC's 2019 F-3 and Barclays Bank PLC's predecessor shelf registration statement on Form F-3 filed in 2018 (Predecessor Shelf) with a value of £6,997m have been classified as "on demand".

2

The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.

3

Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year.

4

Includes structured notes of £48.4bn, of which £9.4bn matures within one year.

 

Regulatory minimum requirements

 

Capital

 

The Group's Overall Capital Requirement for CET1 is 11.3% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0.4% Countercyclical Capital Buffer (CCyB).

 

The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 13 December 2021, the Financial Policy Committee (FPC) announced the re-introduction of a CCyB rate of 1% for UK exposures with effect from 13 December 2022. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.4% CCyB for the Group. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% with effect from 5 July 2023.

 

The Group's updated Pillar 2A requirement as per the PRA's Individual Capital requirement is 4.3% of which at least 56.25% needs to be met with CET1 capital, equating to 2.4% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.

 

The Group's CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer.

 

Leverage

 

The Group is subject to a UK leverage ratio requirement of 4.0%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.2%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB and CCLB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £5.9bn and against the 0.2% CCLB was £2.3bn.

 

The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.

 

MREL

 

The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.3% Pillar 2A equating to 24.5% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.

 

Significant regulatory updates in the period

 

Capital and RWAs

 

On 1 January 2022, the PRA's implementation of Basel III standards took effect including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and the introduction of the Standardised Approach for Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method for Standardised derivative exposures as a more risk sensitive approach. In addition, the PRA also implemented IRB roadmap changes which includes revisions to the criteria for definition of default, probability of default and loss given default estimation to ensure supervisory consistency and increase transparency of IRB models.

 

On 30 November 2022, the PRA published its consultation paper 'Implementation of the Basel 3.1 standards', which covers the remaining parts of the Basel III standards to be implemented in the UK. Changes are expected to come in to force from 1 January 2025, other than those areas subject to transitional provisions. Barclays currently expects the impact on RWAs on 1 January 2025 to be at the lower end of the prior 5-10% RWA inflation guidance. The PRA is currently consulting on the rule changes, and there will be a review of the Pillar 2A framework in 2024 which may offset some of the impact.

 

Leverage

 

From 1 January 2022, UK banks became subject to a single UK leverage ratio requirement meaning that the CRR leverage ratio no longer applies. Under the revised UK leverage ratio framework, central bank claims have been excluded from the UK leverage exposure measure where they are matched by qualifying liabilities (rather than deposits).

 

In the disclosures that follow, references to CRR, as amended by CRR II, mean the capital regulatory requirements, as they form part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

Impact of Over-issuance of Securities in the US

 

Basis of preparation

 

In March 2022, the Group became aware that Barclays Bank PLC had issued securities materially in excess of the amount it had registered with the SEC under Barclays Bank PLC's 2019 F-3. Subsequently, the Group became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities issued in excess of the registered amount included structured products and exchange traded notes. As these securities were not issued in compliance with the Securities Act, a right of rescission arose for certain purchasers of the securities. A portion of the costs associated with the right of rescission was attributable to the financial statements for the year ended 31 December 2021, resulting in the restatement of the 2021 figures in the disclosures below.

 

Prior to the restatement, litigation and conduct charges in the income statement in relation to 2021 were underreported by £220m (pre-tax). This resulted in a CET1 capital decrease of £170m from £47,497m to £47,327m. Both the transitional and fully loaded CET1 ratios remained unchanged at 15.1% and 14.7% respectively. The T1 ratio moved from 19.2% to 19.1% and the total capital ratio moved from 22.3% to 22.2%.

 

The leverage exposure increased £1.9bn to recognise on a regulatory basis, the potential commitment relating to the rescission offer. This resulted in the UK leverage ratio moving from 5.3% to 5.2% whilst the average UK leverage ratio remained unchanged at 4.9%.

 

Total own funds and eligible liabilities decreased £0.2bn to £108bn, which was in excess of a restated requirement to hold £94bn of own funds and eligible liabilities.

 

Restated1

Capital ratios2,3

As at 31.12.22

As at 30.09.22

As at 31.12.21

CET1

13.9%

13.8%

15.1%

T1

17.9%

17.6%

19.1%

Total regulatory capital

20.8%

20.3%

22.2%

Capital resources

£m

£m

£m

Total equity excluding non-controlling interests per the balance sheet

68,292

67,034

69,052

Less: other equity instruments (recognised as AT1 capital)

(13,284)

(13,270)

(12,259)

Adjustment to retained earnings for foreseeable ordinary share dividends

(787)

(494)

(666)

Adjustment to retained earnings for foreseeable repurchase of shares

-

(9)

-

Adjustment to retained earnings for foreseeable other equity coupons

(37)

(82)

(32)

Other regulatory adjustments and deductions

Additional value adjustments (PVA)

(1,726)

(1,850)

(1,585)

Goodwill and intangible assets

(8,224)

(8,356)

(6,804)

Deferred tax assets that rely on future profitability excluding temporary differences

(1,500)

(1,034)

(1,028)

Fair value reserves related to gains or losses on cash flow hedges

7,237

9,451

852

Excess of expected losses over impairment

(119)

(7)

-

Gains or losses on liabilities at fair value resulting from own credit

(620)

(773)

892

Defined benefit pension fund assets

(3,430)

(3,162)

(2,619)

Direct and indirect holdings by an institution of own CET1 instruments

(20)

(20)

(50)

Adjustment under IFRS 9 transitional arrangements

700

759

1,229

Other regulatory adjustments

396

387

345

CET1 capital

46,878

48,574

47,327

AT1 capital

Capital instruments and related share premium accounts

13,284

13,270

12,259

Qualifying AT1 capital (including minority interests) issued by subsidiaries

-

-

637

Other regulatory adjustments and deductions

(60)

(60)

(80)

AT1 capital

13,224

13,210

12,816

T1 capital

60,102

61,784

60,143

T2 capital

Capital instruments and related share premium accounts

9,000

8,524

8,713

Qualifying T2 capital (including minority interests) issued by subsidiaries

1,095

1,176

1,113

Credit risk adjustments (excess of impairment over expected losses)

35

-

73

Other regulatory adjustments and deductions

(160)

(160)

(160)

Total regulatory capital

70,072

71,324

69,882

Total RWAs

336,518

350,774

314,136

 

1

Capital metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for more information. The transitional CET1 ratio remains unchanged at 15.1%.

2

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments. December 2021 comparatives include the grandfathering of CRR non-compliant capital instruments.

3

The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.7%, with £46.2bn of CET1 capital and £336.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II.

 

Movement in CET1 capital

Three months ended 31.12.22

Twelve months ended 31.12.22

£m

£m

Opening CET1 capital1

48,574

47,327

Profit for the period attributable to equity holders

1,321

5,928

Own credit relating to derivative liabilities

90

(85)

Ordinary share dividends paid and foreseen

(293)

(1,149)

Purchased and foreseeable share repurchase

-

(1,500)

Other equity coupons paid and foreseen

(240)

(910)

Increase in retained regulatory capital generated from earnings

878

2,284

Net impact of share schemes

99

108

Fair value through other comprehensive income reserve

(26)

(1,277)

Currency translation reserve

(1,401)

2,032

Other reserves

(4)

138

(Decrease)/increase in other qualifying reserves

(1,332)

1,001

Pension remeasurements within reserves

(606)

(281)

Defined benefit pension fund asset deduction

(268)

(811)

Net impact of pensions

(874)

(1,092)

Additional value adjustments (PVA)

124

(141)

Goodwill and intangible assets

132

(1,420)

Deferred tax assets that rely on future profitability excluding those arising from temporary differences

(466)

(472)

Excess of expected loss over impairment

(112)

(119)

Direct and indirect holdings by an institution of own CET1 instruments

-

30

Adjustment under IFRS 9 transitional arrangements

(59)

(529)

Other regulatory adjustments

13

9

(Decrease) in regulatory capital due to adjustments and deductions

(368)

(2,642)

Closing CET1 capital

46,878

46,878

 

1

Opening balance as at 1 January 2022 has been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for more information

 

CET1 capital decreased £0.4bn to £46.9bn (December 2021: £47.3bn).

 

CET1 capital decreased by £1.7bn as a result of regulatory changes that took effect from 1 January 2022 including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and a reduction in IFRS9 transitional relief due to the relief applied to the pre-2020 impairment charge reducing to 25% in 2022 from 50% in 2021 and the relief applied to the post-2020 impairment charge reducing to 75% in 2022 from 100% in 2021.

 

£5.9bn of capital generated from profit, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities, was partially offset by distributions of £3.5bn comprising:

·

£1.5bn of total buybacks including the £1bn buyback announced with FY21 results and the £0.5bn buyback announced with H122 results

·

£1.1bn of ordinary share dividends paid and foreseen reflecting the £0.4bn half year 2022 dividend paid and a £0.8bn accrual towards a full year 2022 dividend

·

£0.9bn of equity coupons paid and foreseen

Other significant movements in the period were:

·

£1.3bn reduction from decreases in the fair value of the bond portfolio through other comprehensive income

·

£2.0bn increase in the currency translation reserve driven by the appreciation of period end USD against GBP

·

£1.1bn decrease due to the net impact of pensions primarily as a result of the accelerated cash settlement to the UKRF of earlier deficit reduction contributions as well as deficit reduction payments made in 2022

 

RWAs by risk type and business

Credit risk

Counterparty credit risk

Market Risk

Operational risk

Total RWAs

STD

IRB

STD

IRB

Settlement Risk

CVA

STD

IMA

As at 31.12.22

£m

£m

£m

£m

£m

£m

£m

£m

£m

£m

Barclays UK

6,836

54,752

167

-

-

72

233

-

11,023

73,083

Corporate and Investment Bank

35,738

75,413

16,814

21,449

80

3,093

13,716

22,497

27,064

215,864

Consumer, Cards and Payments

27,882

3,773

214

46

-

61

-

388

6,559

38,923

Barclays International

63,620

79,186

17,028

21,495

80

3,154

13,716

22,885

33,623

254,787

Head Office

2,636

6,843

-

-

-

-

-

-

(831)

8,648

Barclays Group

73,092

140,781

17,195

21,495

80

3,226

13,949

22,885

43,815

336,518

As at 30.09.22

Barclays UK

6,487

55,121

246

-

-

84

256

-

11,047

73,241

Corporate and Investment Bank

38,886

75,561

20,115

24,735

446

3,111

15,596

26,879

25,296

230,625

Consumer, Cards and Payments

28,180

3,597

279

35

-

69

-

104

6,424

38,688

Barclays International

67,066

79,158

20,394

24,770

446

3,180

15,596

26,983

31,720

269,313

Head Office

2,785

6,431

-

-

-

-

-

-

(996)

8,220

Barclays Group

76,338

140,710

20,640

24,770

446

3,264

15,852

26,983

41,771

350,774

As at 31.12.21

Barclays UK

7,195

53,408

426

-

-

138

100

-

11,022

72,289

Corporate and Investment Bank

29,420

64,416

15,223

19,238

105

2,289

17,306

27,308

25,359

200,664

Consumer, Cards and Payments

20,770

2,749

215

18

-

21

-

57

6,391

30,221

Barclays International

50,190

67,165

15,438

19,256

105

2,310

17,306

27,365

31,750

230,885

Head Office

4,733

7,254

-

-

-

-

-

-

(1,025)

10,962

Barclays Group

62,118

127,827

15,864

19,256

105

2,448

17,406

27,365

41,747

314,136

 

Movement analysis of RWAs

Credit risk

Counterparty credit risk

Market risk

Operational risk

Total RWAs

£m

£m

£m

£m

£m

Opening RWAs (as at 31.12.21)

189,945

37,673

44,771

41,747

314,136

Book size

15,371

(3,254)

(9,707)

2,068

4,478

Acquisitions and disposals

(1,187)

-

-

-

(1,187)

Book quality

(2,236)

1,320

-

-

(916)

Model updates

-

-

-

-

-

Methodology and policy

2,961

2,952

-

-

5,913

Foreign exchange movements1

9,019

3,305

1,770

-

14,094

Total RWA movements

23,928

4,323

(7,937)

2,068

22,382

Closing RWAs (as at 31.12.22)

213,873

41,996

36,834

43,815

336,518

 

1

Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.

 

Overall RWAs increased £22.4bn to £336.5bn (December 2021: £314.1bn)

 

Credit risk RWAs increased £23.9bn:

·

A £15.4bn increase in book size primarily driven by an increase in lending activities across CIB, CC&P and growth in mortgages within Barclays UK

·

A £1.2bn decrease in acquisitions and disposals primarily driven by the disposal of Barclays' equity stake in Absa, offset by Gap portfolio acquisition

·

A £2.2bn decrease in RWAs due to book quality primarily driven by the benefit in mortgages from an increase in the HPI, partially offset by movements in risk parameters primarily within Barclays UK

·

A £3.0bn increase in methodology and policy primarily as a result of regulatory changes relating to implementation of IRB roadmap changes, partially offset by the reversal of the software intangibles benefit

·

A £9.0bn increase in FX primarily due to appreciation of USD against GBP

Counterparty Credit risk RWAs increased £4.3bn:

·

A £3.3bn decrease in book size primarily driven by derivative mark-to-market movements

·

A £1.3bn increase in RWAs due to book quality primarily driven by movements in risk parameters within CIB

·

A £3.0bn increase in methodology and policy as a result of regulatory changes relating to the introduction of SA-CCR

·

A £3.3bn increase in FX primarily due to appreciation of USD against GBP

Market risk RWAs decreased £7.9bn:

·

A £9.7bn decrease in book size primarily driven by a £6.7bn in Stressed Value at Risk (SVaR) model adjustment as a result of changes in portfolio composition, a £2.3bn decrease due to client and trading activities and a £0.7bn reduction in Structural FX

·

A £1.8bn increase in FX primarily due to appreciation of USD against GBP

Operational risk RWAs increased £2.1bn:

·

A £2.1bn increase in book size primarily driven by the inclusion of higher 2022 CIB income compared to 2019

 

Restated1

Leverage ratios2,3

As at 31.12.22

As at 30.09.22

As at 31.12.21

£m

£m

£m

Average UK leverage ratio

4.8%

4.8%

4.9%

Average T1 capital

60,865

60,651

59,739

Average UK leverage exposure

1,280,972

1,259,648

1,229,041

UK leverage ratio

5.3%

5.0%

5.2%

CET1 capital

46,878

48,574

47,327

AT1 capital

13,224

13,210

12,179

T1 capital

60,102

61,784

59,506

UK leverage exposure

1,129,973

1,232,105

1,137,904

UK leverage exposure

Accounting assets

Derivative financial instruments

302,380

416,908

262,572

Derivative cash collateral

69,048

90,948

58,177

Securities financing transactions (SFTs)

189,637

224,978

170,853

Loans and advances and other assets

952,634

994,065

892,683

Total IFRS assets

1,513,699

1,726,899

1,384,285

Regulatory consolidation adjustments

(8,278)

(6,598)

(3,665)

Derivatives adjustments

Derivatives netting

(256,309)

(347,999)

(236,881)

Adjustments to collateral

(52,715)

(76,083)

(50,929)

Net written credit protection

16,190

26,838

15,509

Potential future exposure (PFE) on derivatives

84,168

84,597

137,291

Total derivatives adjustments

(208,666)

(312,647)

(135,010)

SFTs adjustments

24,203

30,477

24,544

Regulatory deductions and other adjustments

(21,447)

(21,582)

(20,219)

Weighted off-balance sheet commitments

124,169

135,222

115,047

Qualifying central bank claims

(272,321)

(267,792)

(210,134)

Settlement netting

(21,386)

(51,874)

(16,944)

UK leverage exposure

1,129,973

1,232,105

1,137,904

 

1

Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for further details.

2

Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II.

3

Fully loaded average UK leverage ratio was 4.7%, with £60.1bn of T1 capital and £1,280.2bn of leverage exposure. Fully loaded UK leverage ratio was 5.3%, with £59.4bn of T1 capital and £1,129.3bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II.

 

The UK leverage ratio increased to 5.3% (December 2021: 5.2%) primarily due to a £7.9bn decrease in the leverage exposure and a £0.6bn increase in Tier 1 capital. The UK leverage exposure decreased to £1,130.0bn (December 2021: £1,137.9bn) largely due to the following movements:

 

·

£53.1bn decrease in PFE on derivatives largely driven by increased netting eligibility due to the introduction of SA-CCR

·

£42.0bn decrease in cash at central banks net of the qualifying central bank claims exemption primarily due to the matching of allowable liabilities rather than deposits introduced under the UK leverage ratio framework and a decrease in Swiss Franc cash assets

·

£33.0bn increase in loans and advances and other assets (excluding cash and settlement balances which are subject to regulatory exemptions) primarily due to increased lending

·

£29.5bn increase in derivative financial instruments post additional regulatory netting and adjustments for cash collateral primarily driven by market volatility, increased activity in CIB and the application of a 1.4 multiplier introduced under SA-CCR

·

£18.4bn increase in SFTs primarily driven by increased reverse repurchase activity in CIB

 

The average UK leverage ratio decreased to 4.8% (December 2021: 4.9%) due to a £51.9bn increase in average leverage exposure partially offset by a £1.1bn increase in average T1 capital. The average UK leverage exposure increased to £1,281.0bn (December 2021: £1,229.0bn) mainly driven by increased activity during the year that was partially offset by the impact of regulatory changes that came into effect from 1 January 2022 under the UK leverage ratio framework.

 

MREL

MREL requirements including buffers1,2,3,4

Total requirement (£m) based on

Requirement as a percentage of:

Restated1

Restated1

As at 31.12.22

As at 30.09.22

As at 31.12.21

As at 31.12.22

As at 30.09.22

As at 31.12.21

Requirement based on RWAs (minimum requirement)

97,387

99,596

77,302

28.9%

28.4%

24.6%

Requirement based on UK leverage exposure4

91,213

97,243

93,975

8.1%

7.9%

6.9%

Restated1

Own funds and eligible liabilities1,3

As at 31.12.22

As at 30.09.22

As at 31.12.21

£m

£m

£m

CET1 capital

46,878

48,574

47,327

AT1 capital instruments and related share premium accounts5

13,224

13,210

12,179

T2 capital instruments and related share premium accounts5

8,875

8,364

8,626

Eligible liabilities

43,851

41,744

39,889

Total Barclays PLC (the Parent company) own funds and eligible liabilities

112,828

111,892

108,021

Total RWAs

336,518

350,774

314,136

Total UK leverage exposure4

1,129,973

1,232,105

1,356,191

Restated1

Own funds and eligible liabilities ratios as a percentage of:1

As at 31.12.22

As at 30.09.22

As at 31.12.21

Total RWAs

33.5%

31.9%

34.4%

Total UK leverage exposure4

10.0%

9.1%

8.0%

 

As at 31 December 2022, Barclays PLC (the Parent company) held £112.8bn of own funds and eligible liabilities equating to 33.5% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £97.4bn of own funds and eligible liabilities equating to 28.9% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer.

 

1

Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 for further details.

2

Minimum requirement excludes the confidential institution-specific PRA buffer.

3

CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II including IFRS 9 transitional arrangements.

4

As at 31 December 2021, MREL requirements were on a CRR leverage basis which, from 1 January 2022, was no longer applicable for UK banks.

5

Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2021: £80m), and other T2 credit risk adjustments and deductions of £125m (December 2021: £87m).

 

Statement of Directors' Responsibilities

 

Each of the Directors (the names of whom are set out below) confirm that:

 

·

to the best of their knowledge, the condensed consolidated financial statements (set out on pages 64 to 68), which have been prepared in accordance with (a) UK-adopted international accounting standards; and (b) International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB), including interpretations issued by the IFRS Interpretations Committee, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole. The condensed consolidated financial statements should be read in conjunction with the annual financial statements as included in the Annual Report for the year ended 31 December 2022; and

·

to the best of their knowledge, the management information (set out on pages 1 to 62) includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face. This management information should be read in conjunction with the principal risks and uncertainties included in the Annual Report for the year ended 31 December 2022.

 

Signed on 14 February 2023 on behalf of the Board by

 

C.S. Venkatakrishnan

Anna Cross

Group Chief Executive

Group Finance Director

 

Barclays PLC Board of Directors

 

Chairman

Executive Directors

Non-Executive Directors

Nigel Higgins

C.S. Venkatakrishnan

Mike Ashley

Anna Cross

Robert Berry

Tim Breedon CBE

Mohamed A. El-Erian

Dawn Fitzpatrick

Mary Francis CBE

Crawford Gillies

Brian Gilvary

Marc Moses

Diane Schueneman

Julia Wilson

 

 

Condensed Consolidated Financial Statements

 

Condensed consolidated income statement

Restated2

Notes1

Year ended 31.12.22

Year ended 31.12.21

£m

£m

Interest and similar income

19,096

11,240

Interest and similar expense

(8,524)

(3,167)

Net interest income

10,572

8,073

Fee and commission income

9,637

9,880

Fee and commission expense

(3,038)

(2,206)

Net fee and commission income

6,599

7,674

Net trading income

8,049

5,794

Net investment income

(434)

311

Other income

170

88

Total income

24,956

21,940

Staff costs

(9,252)

(8,511)

Infrastructure, administration and general expenses

(5,881)

(5,751)

Litigation and conduct

(1,597)

(397)

Operating expenses

(16,730)

(14,659)

Share of post-tax results of associates and joint ventures

6

260

Profit before impairment

8,232

7,541

Credit impairment (charges)/releases

(1,220)

653

Profit before tax

7,012

8,194

Tax charge

2

(1,039)

(1,138)

Profit after tax

5,973

7,056

Attributable to:

Equity holders of the parent

5,023

6,205

Other equity instrument holders

905

804

Total equity holders of the parent

5,928

7,009

Non-controlling interests

3

45

47

Profit after tax

5,973

7,056

Earnings per share

p

p

Basic earnings per ordinary share

4

30.8

36.5

Diluted earnings per ordinary share

4

29.8

35.6

 

1

For Notes to the Financial Statements see pages 69 to 76.

2

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

Condensed consolidated statement of comprehensive income

 

Restated2

 

Year ended 31.12.22

Year ended 31.12.21

 

Notes1

£m

£m

 

Profit after tax

5,973

7,056

 

 

Other comprehensive income/(loss) that may be recycled to profit or loss:3

 

Currency translation reserve

12

2,032

(131)

 

Fair value through other comprehensive income reserve

12

(1,421)

(429)

 

Cash flow hedging reserve

12

(6,382)

(2,428)

 

Other comprehensive loss that may be recycled to profit

(5,771)

(2,988)

 

 

Other comprehensive income/(loss) not recycled to profit or loss:3

Retirement benefit remeasurements

9

(281)

643

 

Fair value through other comprehensive income reserve

12

228

141

 

Own credit

12

1,463

(14)

 

Other comprehensive income not recycled to profit

1,410

770

 

 

Other comprehensive loss for the period

(4,361)

(2,218)

 

 

Total comprehensive income for the period

1,612

4,838

 

 

Attributable to:

 

Equity holders of the parent

1,567

4,791

 

Non-controlling interests

45

47

 

Total comprehensive income for the period

1,612

4,838

 

 

1

For Notes to the Financial Statements see pages 69 to 76.

2

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

3

Reported net of tax.

 

Condensed consolidated balance sheet

Restated2

As at 31.12.22

As at 31.12.21

Assets

Notes1

£m

£m

Cash and balances at central banks

256,351

238,574

Cash collateral and settlement balances

112,597

92,542

Loans and advances at amortised cost

398,779

361,451

Reverse repurchase agreements and other similar secured lending

776

3,227

Trading portfolio assets

133,813

147,035

Financial assets at fair value through the income statement

213,568

191,972

Derivative financial instruments

302,380

262,572

Financial assets at fair value through other comprehensive income

65,062

61,753

Investments in associates and joint ventures

922

999

Goodwill and intangible assets

8,239

8,061

Property, plant and equipment

3,616

3,555

Current tax assets

385

261

Deferred tax assets

2

6,991

4,619

Retirement benefit assets

9

4,743

3,879

Other assets

5,477

3,785

Total assets

1,513,699

1,384,285

Liabilities

Deposits at amortised cost

545,782

519,433

Cash collateral and settlement balances

96,927

79,371

Repurchase agreements and other similar secured borrowing

27,052

28,352

Debt securities in issue

112,881

98,867

Subordinated Liabilities

7

11,423

12,759

Trading portfolio liabilities

72,924

54,169

Financial liabilities designated at fair value

271,637

250,960

Derivative financial instruments

289,620

256,883

Current tax liabilities

580

689

Deferred tax liabilities

2

16

37

Retirement benefit liabilities

9

264

311

Other liabilities

13,789

10,505

Provisions

8

1,544

1,908

Total liabilities

1,444,439

1,314,244

Equity

Called up share capital and share premium

10

4,373

4,536

Other reserves

12

(2,192)

1,770

Retained earnings

52,827

50,487

Shareholders' equity attributable to ordinary shareholders of the parent

55,008

56,793

Other equity instruments

11

13,284

12,259

Total equity excluding non-controlling interests

68,292

69,052

Non-controlling interests

3

968

989

Total equity

69,260

70,041

Total liabilities and equity

1,513,699

1,384,285

 

1

For Notes to the Financial Statements see pages 69 to 76.

2

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

Condensed consolidated statement of changes in equity

Called up share capital and share premium

Other equity instruments

Other reserves

Restated1

 

Retained earnings

Restated1

 

 

Total

Non-controlling interests

Restated1

 

Total equity

Year ended 31.12.2022

£m

£m

£m

£m

£m

£m

£m

Balance as at 1 January 2022

4,536

12,259

1,770

50,487

69,052

989

70,041

Profit after tax

-

905

-

5,023

5,928

45

5,973

Retirement benefit remeasurements

-

-

-

(281)

(281)

-

(281)

Other comprehensive profit after tax for the year

-

-

(4,080)

-

(4,080)

-

(4,080)

Total comprehensive income for the period

-

905

(4,080)

4,742

1,567

45

1,612

Employee share schemes and hedging thereof

70

-

-

476

546

-

546

Issue and redemption of other equity instruments

-

1,032

-

28

1,060

(20)

1,040

Other equity instruments coupon paid

-

(905)

-

-

(905)

-

(905)

Disposal of Absa holding

-

-

(84)

84

-

-

-

Vesting of employee share schemes

-

-

5

(485)

(480)

-

(480)

Dividends paid

-

-

-

(1,028)

(1,028)

(45)

(1,073)

Repurchase of shares

(233)

-

233

(1,508)

(1,508)

-

(1,508)

Own credit realisation

-

-

(36)

36

-

-

-

Other movements

-

(7)

-

(5)

(12)

(1)

(13)

Balance as at 31 December 2022

4,373

13,284

(2,192)

52,827

68,292

968

69,260

 

Year ended 31.12.2021

Balance as at 1 January 2021

4,637

11,172

4,461

45,527

65,797

1,085

66,882

Profit after tax

-

804

-

6,205

7,009

47

7,056

Retirement benefit remeasurements

-

-

-

643

643

-

643

Other comprehensive profit after tax for the year

-

-

(2,861)

-

(2,861)

-

(2,861)

Total comprehensive income for the period

-

804

(2,861)

6,848

4,791

47

4,838

Employee share schemes and hedging thereof

60

-

-

235

295

-

295

Issue and redemption of other equity instruments

-

1,078

-

6

1,084

(75)

1,009

Other equity instruments coupon paid

-

(804)

-

-

(804)

-

(804)

Vesting of employee share schemes

-

-

1

(410)

(409)

-

(409)

Dividends paid

-

-

-

(512)

(512)

(44)

(556)

Repurchase of shares

(161)

-

161

(1,200)

(1,200)

-

(1,200)

Other movements

-

9

8

(7)

10

(24)

(14)

Balance as at 31 December 2021

4,536

12,259

1,770

50,487

69,052

989

70,041

 

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

Condensed consolidated cash flow statement

Restated1

Year ended 31.12.22

Year ended 31.12.21

£m

£m

Profit before tax

7,012

8,194

Adjustment for non-cash items

(8,514)

5,023

Net increase in loans and advances at amortised cost

(24,949)

(10,728)

Net increase in deposits at amortised cost

26,349

38,397

Net increase in debt securities in issue

9,210

18,131

Changes in other operating assets and liabilities

21,811

(8,763)

Corporate income tax paid

(688)

(1,335)

Net cash from operating activities

30,231

48,919

Net cash from investing activities

(21,673)

4,270

Net cash from financing activities

696

107

Effect of exchange rates on cash and cash equivalents

10,330

(4,232)

Net increase in cash and cash equivalents

19,584

49,064

Cash and cash equivalents at beginning of the period

259,206

210,142

Cash and cash equivalents at end of the period

278,790

259,206

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

Financial Statement Notes

 

1. Basis of preparation

 

Restatement of financial statements

 

The comparatives in these condensed consolidated financial statements for the year ended 31 December 2022 (the financial statements) have been restated to reflect both a provision and contingent liability disclosure in respect of the impact of an over-issuance of securities (the Over-issuance of Securities) in excess of the maximum aggregate offering price registered under Barclays Bank PLC's shelf registration statement on Form F-3, as declared effective by the SEC in August 2019 (2019 F-3) and Barclays Bank PLC's Predecessor Shelf.

 

Due to an SEC settlement order in 2017, at the time the 2019 F-3 was filed and the Predecessor Shelf was amended, Barclays Bank PLC had ceased to be a "well-known seasoned issuer" (or WKSI) and had become an "ineligible issuer", as defined in Rule 405 under the Securities Act of 1933, as amended (Securities Act), thus being required to register upfront a fixed amount of securities with the SEC.

 

In March 2022, Barclays Bank PLC became aware that it had issued securities in the US materially in excess of the amount it had registered with the SEC under the 2019 F-3. Subsequently, Barclays Bank PLC became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities that were issued in this period included structured notes and exchange traded notes (ETNs). Certain offers and sales of these securities were not made in compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the securities. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser sold the securities at a loss (the Rescission Price). As a result, Barclays Bank PLC made a rescission offer to eligible purchasers of the relevant affected securities at the Rescission Price (the Rescission Offer).

 

A portion of the costs associated with the rights of rescission of certain investors was attributable to Barclays PLC's financial statements for the year ended 31 December 2021. Accordingly, the comparatives in these financial statements have been restated. The restatement impacts the consolidated income statement, the consolidated statement of comprehensive income, the consolidated balance sheet, the consolidated statement of changes in equity, and the consolidated cash flow statement for the year ended 31 December 2021, as well as quarterly financial information that is presented within this document.

 

The table below reflects each of the consolidated financial statement line items that were affected by the restatement:

 

Impact on the condensed consolidated income statement

As reported

Restatement

As restated

Year ended 31.12.21

£m

£m

£m

Litigation and conduct

(177)

(220)

(397)

Operating expenses

(14,439)

(220)

(14,659)

Profit before tax

8,414

(220)

8,194

Taxation

(1,188)

50

(1,138)

Profit after tax

7,226

(170)

7,056

Impact on the condensed consolidated statement of comprehensive income

Year ended 31.12.21

£m

£m

£m

Profit after tax

7,226

(170)

7,056

Total comprehensive income for the period

5,008

(170)

4,838

Impact on the condensed consolidated cash flow statement

Year ended 31.12.21

£m

£m

£m

Profit before tax

8,414

(220)

8,194

Adjustment for non-cash items

4,803

220

5,023

Impact on the condensed consolidated balance sheet

As at 31.12.21

£m

£m

£m

Current tax liabilities

739

(50)

689

Provisions

1,688

220

1,908

Total liabilities

1,314,074

170

1,314,244

Retained earnings

50,657

(170)

50,487

Total equity

70,211

(170)

70,041

 

2. Tax

 

The tax charge for 2022 was £1,039m (restated1 2021: £1,138m), representing an effective tax rate (ETR) of 14.8% (restated1 2021: 13.9%). The ETR for 2022 includes a charge recognised for the re-measurement of the Group's UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 to reduce the UK banking surcharge rate being from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 9.9%, reflecting the impact of tax benefits arising in the current year, primarily arising from tax relief related to government bonds linked to the high prevailing rate of inflation in 2022, as well as beneficial adjustments in respect of prior years. Included in the 2022 tax charge is a credit of £244m (2021: £212m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes. The 2021 ETR included a benefit recognised for the re-measurement of the Group's UK DTAs as a result of the enactment of legislation to increase the UK Corporation Tax rate to 25% effective from 1 April 2023.

 

The re-measurement of UK DTAs has resulted in the Group's DTAs decreasing by £318m with a tax charge in the income statement of £346m and a tax credit within other comprehensive income of £28m.

 

In its Autumn Statement held in November 2022, the UK Government confirmed that, as currently enacted, the banking surcharge rate will be reduced from 8% to 3% from 1 April 2023. UK deferred tax assets as at 31 December 2022 are measured at this rate, having been remeasured when the 3% rate was substantively enacted in 2022. The statutory tax rate applicable to banks' UK profits will therefore be 28% (comprising a rate of 25% for Corporation Tax and of 3% for banking surcharge)from 1 April 2023.

 

The OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce a global minimum tax rate of 15% and the OECD issued model rules in 2021. During 2022 further OECD guidance has been released and draft legislation to implement the global minimum tax regime has been published by the UK Government. The UK Government has stated that it intends to enact legislation in 2023 to apply for accounting periods beginning on or after 31 December 2023. The Group has reviewed the published OECD model rules and further guidance along with the draft UK legislation and has been assessing the expected impact ahead of the implementation of the new regime. The Group will review further guidance as well as new legislation expected to be released by governments implementing this new tax regime and continue to assess the potential impact.

 

In the USA, the Inflation Reduction Act was enacted in August 2022. The Act does not include changes to the US corporate income tax rate or to US international tax provisions included in the previously proposed Build Back Better Act but does introduce a corporate alternative minimum tax on adjusted financial statements income, effective from 1 January 2023. Further regulations and guidance are expected to be published in 2023, however the Group's preliminary view is that the alternative minimum tax is not expected to materially increase the Group's effective tax rate. The Group will review future guidance when it is published and continue to monitor other legislative developments and assess the potential impact.

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

As at 31.12.22

As at 31.12.21

Deferred tax assets and liabilities

£m

£m

UK

4,925

2,183

USA

1,576

2,006

Other territories

490

430

Deferred tax assets

6,991

4,619

Deferred tax liabilities

(16)

(37)

Analysis of deferred tax assets

Temporary differences

5,345

3,399

Tax losses

1,646

1,220

Deferred tax assets

6,991

4,619

 

 

3. Non-controlling interests

 

Profit attributable to

non-controlling interests

Equity attributable to

non-controlling interests

Year ended 31.12.22

Year ended 31.12.21

As at 31.12.22

As at 31.12.21

£m

£m

£m

£m

Barclays Bank PLC issued:

- Preference shares

31

27

529

529

- Upper T2 instruments

14

17

438

458

Other non-controlling interests

-

3

1

2

Total

45

47

968

989

 

 

4. Earnings per share

 

Restated1

Year ended 31.12.22

Year ended 31.12.21

£m

£m

Profit attributable to ordinary equity holders of the parent

5,023

6,205

m

m

Basic weighted average number of shares in issue

16,333

16,985

Number of potential ordinary shares

534

435

Diluted weighted average number of shares

16,867

17,420

p

p

Basic earnings per ordinary share

30.8

36.5

Diluted earnings per ordinary share

29.8

35.6

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

5. Dividends on ordinary shares

 

It is Barclays' policy to declare and pay dividends on a semi-annual basis. The 2022 full year dividend of 5.0p per ordinary share will be paid on 31 March 2023 to the shareholders on the Share Registrar on 24 February 2023. A half year dividend for 2022 of 2.25p (H121: 2.0p) per ordinary share was paid on 16 September 2022.

 

Year ended 31.12.22

Year ended 31.12.21

Per share

Total

Per share

Total

Dividends paid during the period

p

£m

p

£m

Full year dividend paid during period

4.00

664

1.00

173

Interim dividend paid during the period

2.25

364

2.00

339

Total dividend

6.25

1,028

3.00

512

 

The Directors have confirmed their intention initiate a share buyback of up to £0.5bn after the balance sheet date. The share buyback is expected to commence in the first quarter of 2023. The financial statements for the year ended 31 December 2022 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company.

 

6. Fair value of financial instruments

 

This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2022 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used.

 

Valuation

 

The following table shows the Group's assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:

 

Valuation technique using

Quoted market prices

Observable inputs

Significant unobservable inputs

(Level 1)

(Level 2)

(Level 3)

Total

As at 31.12.22

£m

£m

£m

£m

Trading portfolio assets

62,478

64,855

6,480

133,813

Financial assets at fair value through the income statement

5,720

198,723

9,125

213,568

Derivative financial instruments

10,054

287,152

5,174

302,380

Financial assets at fair value through other comprehensive income

20,704

44,347

11

65,062

Investment property

-

-

5

5

Total assets

98,956

595,077

20,795

714,828

Trading portfolio liabilities

(44,128)

(28,740)

(56)

(72,924)

Financial liabilities designated at fair value

(133)

(270,454)

(1,050)

(271,637)

Derivative financial instruments

(10,823)

(272,434)

(6,363)

(289,620)

Total liabilities

(55,084)

(571,628)

(7,469)

(634,181)

As at 31.12.21

Trading portfolio assets

80,926

63,828

2,281

147,035

Financial assets at fair value through the income statement

5,093

177,167

9,712

191,972

Derivative financial instruments

6,150

252,412

4,010

262,572

Financial assets at fair value through other comprehensive income

22,009

39,706

38

61,753

Investment property

-

-

7

7

Total assets

114,178

533,113

16,048

663,339

Trading portfolio liabilities

(27,529)

(26,613)

(27)

(54,169)

Financial liabilities designated at fair value

(174)

(250,376)

(410)

(250,960)

Derivative financial instruments

(6,571)

(244,253)

(6,059)

(256,883)

Total liabilities

(34,274)

(521,242)

(6,496)

(562,012)

 

 

7. Subordinated liabilities

 

Year ended 31.12.22

Year ended 31.12.21

£m

£m

Opening balance as at 1 January

12,759

16,341

Issuances

1,477

1,890

Redemptions

(2,679)

(4,807)

Other

(134)

(665)

Closing balance

11,423

12,759

 

Issuances of £1,477m comprise £1,000m GBP 8.407% Fixed Rate Resetting Subordinated Callable Notes issued externally by Barclays PLC and £317m USD Floating Rate Notes, £89m ZAR Floating Rate Notes, £42m EUR Floating Rate Notes and £29m JPY Floating Rate Notes issued externally by Barclays subsidiaries.

 

Redemptions of £2,679m comprise £2,349m notes issued externally by Barclays Bank PLC, £175m USD Floating Rate Notes, £88m USD Fixed Rate Notes issued externally by Barclays subsidiaries and £67m GBP Undated Subordinated Loan Notes (secured) issued externally by a Barclays securitisation special purpose vehicle (SPV). £2,349m notes issued externally by Barclays Bank PLC comprise £1,275m USD 7.625% Fixed Rate Contingent Capital Notes, £838m EUR 6.625% Fixed Rate Subordinated Notes, £147m USD 6.86% Callable Perpetual Core Tier One Notes, £42m EUR Subordinated Floating Rate Notes, £35m GBP 5.330% Step-up Callable Perpetual Reserve Capital Instruments and £12m GBP 6% Callable Perpetual Core Tier One Notes.

 

Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.

 

8. Provisions

 

Restated1

As at 31.12.22

As at 31.12.21

£m

£m

Customer redress

378

530

Legal, competition and regulatory matters

159

226

Redundancy and restructuring

136

326

Undrawn contractually committed facilities and guarantees

583

542

Onerous contracts

-

5

Sundry provisions

288

279

Total

1,544

1,908

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 69 for more information.

 

9. Retirement benefits

 

As at 31 December 2022, the Group's IAS 19 net pension surplus across all schemes was £4.5bn (December 2021: £3.6bn). The UK Retirement Fund (UKRF), which is the Group's main scheme, had an IAS 19 net pension surplus of £4.7bn (December 2021: £3.8bn). The movement for the UKRF was driven by payment of £294m deficit reduction contributions and the unwind of senior fixed rate notes (covered below), partially offset by higher than expected inflation.

 

UKRF funding valuations

 

The latest triennial actuarial valuation of the UKRF with an effective date of 30 September 2022 has been completed. The valuation showed a funding surplus of £2bn and a funding level of 108% (2021 update: £0.6bn surplus, funding level 102%). The improvement was mainly due to £294m deficit reduction contributions, changes to views on life expectancy, and inflationary returns on assets relative to liabilities being better than expected.

 

As the UKRF has a funding surplus the 2023 deficit reduction contribution (£286m), agreed as part of the 2019 triennial actuarial valuation, is no longer required, and no recovery plan is needed.

 

During 2019 and 2020, the UKRF subscribed for non-transferable listed senior fixed rate notes for £1.25bn issued by entities consolidated within the Group under IFRS 10. As a result of these transactions, the CET1 impact of the 2019 and 2020 deficit contributions was deferred until 2023, 2024 and 2025 upon maturity of the notes. Barclays unwound these transactions in December 2022. This resulted in a c.30bps reduction to the CET1 ratio being accelerated to Q4 2022 from 2023, 2024 and 2025.

 

10. Called up share capital

 

Ordinary share capital

Share premium

Total share capital and share premium

Year ended 31.12.22

£m

£m

£m

Opening balance as at 1 January

4,188

348

4,536

Issue of shares under employee share schemes

13

57

70

Repurchase of shares

(233)

-

(233)

Closing balance

3,968

405

4,373

 

Called up share capital comprises 15,871m (December 2021: 16,752m) ordinary shares of 25p each. The decrease is mainly due to the repurchase of 931m shares as part of the share buybacks conducted in 2022, partially offset by an increase due to the issuance of shares under employee share schemes.

 

11. Other equity instruments

 

Year ended 31.12.22

Year ended 31.12.21

£m

£m

Opening balance as at 1 January

12,259

11,172

Issuances

3,158

1,078

Redemptions

(2,126)

-

Securities held by the Group

(7)

9

Closing balance

13,284

12,259

 

Other equity instruments of £13,284m (December 2021: £12,259m) comprise AT1 securities issued by Barclays PLC. There were three issuances and two redemptions in the period.

 

The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA.

 

All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%.

 

12. Other reserves

 

As at 31.12.22

As at 31.12.21

£m

£m

Currency translation reserve

4,772

2,740

Fair value through other comprehensive income reserve

(1,560)

(283)

Cash flow hedging reserve

(7,235)

(853)

Own credit reserve

467

(960)

Other reserves and treasury shares

1,364

1,126

Total

(2,192)

1,770

 

Currency translation reserve

 

The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group's net investment in foreign operations, net of the effects of hedging.

 

As at 31 December 2022, there was a credit balance of £4,772m (December 2021: £2,740m credit) in the currency translation reserve. The £2,032m credit movement principally reflects the weakening of GBP against USD during the period.

 

Fair value through other comprehensive income reserve

 

The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through other comprehensive income investments since initial recognition.

 

As at 31 December 2022, there was a debit balance of £1,560m (December 2021: £283m debit) in the reserve. The movement in the year of £1,277m is principally driven by a loss of £1,836m from the decrease in fair value of bonds(net of hedges) due to increasing bond yields, a net loss of £111m transferred to the income statement, gains of £84m transferred to retained earnings on sale of 14.90% equity stake in Absa Group Limited offset by a tax credit of £523m.

 

Cash flow hedging reserve

 

The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss.

 

As at 31 December 2022, there was a debit balance of £7,235m (December 2021: £853m debit) in the cash flow hedging reserve. The decrease of £6,382m principally reflects a £9,052m decrease in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves increased. This is partially offset by a tax credit of £2,331m and £339m of losses transferred to the income statement.

 

Own credit reserve

 

The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods.

 

As at 31 December 2022, there was a credit balance of £467m (December 2021: £960m debit) in the own credit reserve. The movement of £1,427m principally reflects a £2,091m gain from the widening of Barclays' funding spreads partially offset by a tax charge of £616m.

 

Other reserves and treasury shares

 

Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group's various share schemes.

 

As at 31 December 2022, there was a credit balance of £1,364m (December 2021: £1,126m credit) in other reserves and treasury shares. This is driven by an increase of £233m due to the repurchase of 931m shares as part of the share buybacks conducted in 2022 and a £5m movement in the treasury shares balance held in relation to employee share schemes.

 

Appendix: Non-IFRS Performance Measures

 

The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.

 

However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.

 

Non-IFRS performance measures glossary

 

Measure

Definition

Loan: deposit ratio

Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on page 52.

Period end allocated tangible equity

Allocated tangible equity is calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses.

Average tangible shareholders' equity

Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period.

Average allocated tangible equity

Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period.

Return on average tangible shareholders' equity

Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 78 to 80.

Return on average allocated tangible equity

Statutory profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 78 to 81.

Operating expenses excluding litigation and conduct

A measure of total operating expenses excluding litigation and conduct charges.

Operating costs

A measure of total operating expenses excluding litigation and conduct charges and UK bank levy.

Cost: income ratio

Total operating expenses divided by total income.

Loan loss rate

Quoted in basis points and represents total impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 29.

Net interest margin

Net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 24.

Tangible net asset value per share

Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 82.

Performance measures excluding the impact of the Over-issuance of Securities

Calculated by excluding the impact of the Over-issuance of Securities from performance measures. The components of the calculations have been included on page 79.

Profit before impairment

Calculated by excluding credit impairment charges or releases from profit before tax.

 

Returns

 

Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.

 

Profit/(loss) attributable to ordinary equity holders of the parent

Average tangible equity

Return on average tangible equity

For the year ended 31.12.22

£m

£bn

%

Barclays UK

1,877

10.0

18.7

Corporate and Investment Bank

3,364

32.8

10.2

Consumer, Cards and Payments

480

4.8

10.0

Barclays International

3,844

37.6

10.2

Head Office

(698)

0.7

n/m

Barclays Group

5,023

48.3

10.4

For the year ended 31.12.211

Barclays UK

1,756

10.0

17.6

Corporate and Investment Bank

4,032

28.3

14.3

Consumer, Cards and Payments

615

4.1

15.0

Barclays International

4,647

32.4

14.4

Head Office

(198)

5.0

n/m

Barclays Group

6,205

47.3

13.1

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Year ended 31.12.22

Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Return on average tangible shareholders' equity

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

1,877

3,364

480

3,844

(698)

5,023

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

13.6

32.8

5.7

38.5

4.3

56.4

Average goodwill and intangibles

(3.6)

-

(0.9)

(0.9)

(3.6)

(8.1)

Average tangible shareholders' equity

10.0

32.8

4.8

37.6

0.7

48.3

Return on average tangible shareholders' equity

18.7%

10.2%

10.0%

10.2%

n/m

10.4%

 

Year ended 31.12.211

Barclays UK

Corporate and Investment Bank

Consumer, Cards and Payments

Barclays International

Head Office

Barclays Group

Return on average tangible shareholders' equity

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

1,756

4,032

615

4,647

(198)

6,205

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

13.6

28.3

4.8

33.1

8.7

55.4

Average goodwill and intangibles

(3.6)

-

(0.7)

(0.7)

(3.7)

(8.1)

Average tangible shareholders' equity

10.0

28.3

4.1

32.4

5.0

47.3

Return on average tangible shareholders' equity

17.6%

14.3%

15.0%

14.4%

n/m

13.1%

 

Performance measures excluding the impact of the Over-issuance of Securities

 

Corporate and Investment Bank

Attributable profit excluding the impact of the Over-issuance of Securities

Year ended

31.12.22

£m

Attributable profit

3,364

Post-tax impact of the Over-issuance of Securities

(552)

Attributable profit excluding the impact of the Over-issuance of Securities

3,916

Return on average allocated tangible equity

£bn

Average allocated tangible equity

32.8

The impact of the Over-issuance of Securities

0.3

Average allocated tangible equity adjusted for the impact of the Over-issuance of Securities

32.5

Return on average allocated tangible equity

10.2%

The impact of the Over-issuance of Securities

(1.8)%

Return on average allocated tangible equity excluding the impact of the Over-issuance of Securities

12.0%

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Barclays Group

Return on average tangible shareholders' equity

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

1,036

1,512

1,071

1,404

1,079

1,374

2,048

1,704

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average shareholders' equity

54.9

56.8

57.1

56.9

56.1

56.5

54.4

54.4

Average goodwill and intangibles

(8.2)

(8.2)

(8.1)

(8.1)

(8.1)

(8.2)

(7.9)

(7.9)

Average tangible shareholders' equity

46.7

48.6

49.0

48.8

48.0

48.3

46.5

46.5

Return on average tangible shareholders' equity

8.9%

12.5%

8.7%

11.5%

9.0%

11.4%

17.6%

14.7%

 

Barclays UK

Return on average allocated tangible equity

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

474

549

458

396

420

317

721

298

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

13.7

13.5

13.6

13.7

13.6

13.6

13.5

13.5

Average goodwill and intangibles

(3.5)

(3.6)

(3.6)

(3.6)

(3.6)

(3.6)

(3.6)

(3.6)

Average allocated tangible equity

10.2

9.9

10.0

10.1

10.0

10.0

9.9

9.9

Return on average allocated tangible equity

18.7%

22.1%

18.4%

15.6%

16.8%

12.7%

29.1%

12.0%

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Barclays International

Return on average allocated tangible equity

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

625

1,136

783

1,300

818

1,191

1,207

1,431

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

39.9

40.1

38.2

36.0

33.8

32.7

33.0

32.8

Average goodwill and intangibles

(1.0)

(1.0)

(0.9)

(0.9)

(0.9)

(0.9)

(0.6)

(0.5)

Average allocated tangible equity

38.9

39.1

37.3

35.1

32.9

31.8

32.4

32.3

Return on average allocated tangible equity

6.4%

11.6%

8.4%

14.8%

9.9%

14.9%

14.9%

17.7%

 

 

Corporate and Investment Bank

Return on average allocated tangible equity

Q422

Q322

Q222

Q122

Q4211

Q3211

Q2211

Q121

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit

454

1,015

579

1,316

695

1,085

989

1,263

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

33.7

34.0

32.7

30.8

28.7

27.8

28.4

28.2

Average goodwill and intangibles

-

-

-

-

-

-

-

-

Average allocated tangible equity

33.7

34.0

32.7

30.8

28.7

27.8

28.4

28.2

Return on average allocated tangible equity

5.4%

11.9%

7.1%

17.1%

9.7%

15.6%

14.0%

17.9%

 

Consumer, Cards and Payments

Return on average allocated tangible equity

Q422

Q322

Q222

Q122

Q421

Q321

Q221

Q121

£m

£m

£m

£m

£m

£m

£m

£m

Attributable profit/(loss)

171

121

204

(16)

123

106

218

168

£bn

£bn

£bn

£bn

£bn

£bn

£bn

£bn

Average allocated equity

6.2

6.1

5.5

5.2

5.1

4.9

4.6

4.6

Average goodwill and intangibles

(1.0)

(1.0)

(0.9)

(0.9)

(0.9)

(0.9)

(0.6)

(0.5)

Average allocated tangible equity

5.2

5.1

4.6

4.3

4.2

4.0

4.0

4.1

Return on average allocated tangible equity

13.0%

9.5%

17.8%

(1.5)%

11.7%

10.5%

21.8%

16.5%

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Tangible net asset value per share

As at 31.12.22

Restated1

As at 31.12.21

£m

£m

Total equity excluding non-controlling interests

68,292

69,052

Other equity instruments

(13,284)

(12,259)

Goodwill and intangibles

(8,239)

(8,061)

Tangible shareholders' equity attributable to ordinary shareholders of the parent

46,769

48,732

m

m

Shares in issue

15,871

16,752

p

p

Tangible net asset value per share

295

291

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Notable Items

Year ended 31.12.22

Three months ended 31.12.22

£m

 Profit before tax

Attributable profit

Profit before tax

Attributable profit

Statutory

7,012

5,023

1,310

1,036

Net impact from the Over-issuance of Securities

(674)

(552)

-

-

Customer remediation costs on legacy loan portfolio

(282)

(228)

-

-

Settlements in principle in respect of industry-wide devices investigations by SEC and CFTC

(165)

(165)

-

-

Other litigation and conduct

(184)

(167)

(79)

(70)

Re-measurement of UK DTAs

-

(346)

-

-

Excluding the impact of notable items

8,317

6,481

1,389

1,106

Year ended 31.12.21

Three months ended 31.12.21

£m

Profit before tax

Attributable profit

Profit before tax

Attributable profit

Statutory1

8,194

6,205

1,428

1,079

Net impact from the Over-issuance of Securities

(220)

(170)

(46)

(38)

Structural cost action - June 2021 real estate review

(266)

(203)

-

-

Other litigation and conduct

(177)

(136)

(46)

(29)

Re-measurement of UK DTAs

-

462

-

60

Excluding the impact of notable items

8,857

6,252

1,520

1,086

 

The Group's management believes that the non-IFRS financial measures excluding notable items, included in the table above, provide valuable information to enable users of the financial statements to assess the performance of the Group. The notable items are separately identified within the Group's results disclosures which, when excluded from Barclays' statutory financials, provide an underlying profit and loss performance of the Group and enables consistent comparison of performance from one period to another.

 

These non-IFRS financial measures excluding notable items are included as a reference point only and are not incorporated within any of the key financial metrics used in our Group Targets, which are measured on a statutory basis.

 

1

2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 55 and Restatement of financial statements (Note 1) on page 69 for more information.

 

Shareholder Information

 

Results timetable1

Date

Ex-dividend date

23 February 2023

Dividend record date

24 February 2023

Cut off time of 5:00pm (UK time) for the receipt of Dividend Re-investment Programme (DRIP) Application Form Mandate

10 March 2023

Dividend payment date

31 March 2023

Q1 2023 Results Announcement

27 April 2023

For qualifying US and Canadian resident ADR holders, the 2022 full year dividend of 5.0p per ordinary share becomes 20.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above

Year ended

Year ended

Exchange rates2

31.12.22

31.12.21

% Change3

Period end - USD/GBP

1.21

1.35

(10)%

YTD average - USD/GBP

1.24

1.38

(10)%

3 month average - USD/GBP

1.17

1.35

(13)%

Period end - EUR/GBP

1.13

1.19

(5)%

YTD average - EUR/GBP

1.17

1.16

1%

3 month average - EUR/GBP

1.15

1.18

(3)%

Share price data

Barclays PLC (p)

158.52

187.00

Barclays PLC number of shares (m)

15,871

16,752

For further information please contact

Investor relations

Media relations

Chris Manners +44 (0) 20 7773 2136

Tom Hoskin +44 (0) 20 7116 4755

More information on Barclays can be found on our website: home.barclays

Registered office

1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.

Registrar

Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.

Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.

American Depositary Receipts (ADRs)

EQ Shareowner Services

P.O. Box 64504

St. Paul, MN 55164-0854

United States of America

shareowneronline.com

Toll Free Number: +1 800-990-1135

Outside the US +1 651-453-2128

Delivery of ADR certificates and overnight mail

EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA.

 

1

Note that these dates are provisional and subject to change.

2

The average rates shown above are derived from daily spot rates during the year.

3

The change is the impact to GBP reported information.

4

Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR NKQBQKBKBNBD
Date   Source Headline
1st May 20242:44 pmRNSForm 8.3 - Virgin Money UK plc
1st May 20242:42 pmRNSForm 8.3 - UK Commercial Property REIT Limited
1st May 20242:41 pmRNSForm 8.3 - Tritax Big Box REIT plc
1st May 20242:41 pmRNSForm 8.3 - Tyman plc
1st May 20242:39 pmRNSForm 8.3 - Spirent Communications plc
1st May 20242:36 pmRNSForm 8.3 - Quanex Building Products Corporation
1st May 20242:34 pmRNSForm 8.3 - Mattioli Woods plc
1st May 20242:33 pmRNSForm 8.3 - Network International Holdings plc
1st May 20242:31 pmRNSForm 8.3 - Lok’n Store Group plc
1st May 20242:28 pmRNSForm 8.3 - International Paper Company
1st May 20242:24 pmRNSForm 8.3 - Smith (DS) plc
1st May 20242:21 pmRNSForm 8.3 - Darktrace plc
1st May 202411:19 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
1st May 202411:15 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
1st May 202411:13 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
1st May 202411:11 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
1st May 202411:10 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
1st May 202411:08 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
1st May 202411:06 amRNSForm 8.5 (EPT/NON-RI) - BHP Group Limited
1st May 202411:05 amRNSForm 8.5 (EPT/NON-RI) - Anglo American plc
1st May 202410:30 amRNSTotal Voting Rights
1st May 20247:30 amRNSTransaction in Own Shares
30th Apr 20244:35 pmRNSDirector/PDMR Shareholding
30th Apr 20242:30 pmRNSForm 8.3 - Wincanton plc
30th Apr 20242:29 pmRNSForm 8.3 - Virgin Money UK plc
30th Apr 20242:26 pmRNSForm 8.3 - UK Commercial Property REIT Limited
30th Apr 20242:26 pmRNSForm 8.3 - Tyman plc
30th Apr 20242:24 pmRNSForm 8.3 - Tritax Big Box REIT plc
30th Apr 20242:22 pmRNSForm 8.3 - Spirent Communications plc
30th Apr 20242:21 pmRNSForm 8.3 - Quanex Building Products Corporation
30th Apr 20242:19 pmRNSForm 8.3 - Network International Holdings plc
30th Apr 20242:17 pmRNSForm 8.3 - Mattioli Woods plc
30th Apr 20242:17 pmRNSForm 8.3 - Lok’n Store Group plc
30th Apr 20242:15 pmRNSForm 8.3 - International Paper Company
30th Apr 20242:11 pmRNSForm 8.3 - Smith (DS) plc
30th Apr 20242:08 pmRNSForm 8.3 - Darktrace plc
30th Apr 202411:59 amRNSForm 8.5 (EPT/NON-RI)REDROW PLC
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI) BHP GROUP LTD
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI) BARRATT DEVELOPMENTS PLC
30th Apr 202411:58 amRNSForm 8.5 (EPT/NON-RI)ANGLO AMERICAN PLC
30th Apr 202411:57 amRNSForm 8.5 (EPT/NON-RI)BALANCED COMMERCIAL PROP TRUS
30th Apr 202411:57 amRNSForm 8.5 (EPT/NON-RI)INTERNATIONAL DISTRIBUTI SERV
30th Apr 202411:56 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
30th Apr 20247:30 amRNSTransaction in Own Shares
29th Apr 20244:35 pmRNSDirector/PDMR Shareholding
29th Apr 20241:08 pmRNSForm 8.3 - Wincanton plc
29th Apr 20241:07 pmRNSForm 8.3 - Virgin Money UK plc
29th Apr 20241:01 pmRNSForm 8.3 - UK Commercial Property REIT Limited
29th Apr 202412:59 pmRNSForm 8.3 - Tritax Big Box REIT plc
29th Apr 202412:57 pmRNSForm 8.3 - Spirent Communications plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.